http://jnci.oxfordjournals.org/content/97/3/188.full
<!DOCTYPE html
  PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html
      xmlns="http://www.w3.org/1999/xhtml"
      xml:lang="en"
      lang="en">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
      <title>Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis </title>
      <meta name="googlebot" content="NOODP" />
      <meta name="HW.ad-path" content="/cgi/content/full/97/3/188" />
      <meta content="/jnci/97/3/188.atom" name="HW.identifier" />
      <meta name="DC.Format" content="text/html" />
      <meta name="DC.Language" content="en" />
      <meta content="Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis"
            name="DC.Title" />
      <meta content="10.1093/jnci/dji021" name="DC.Identifier" />
      <meta content="2005-02-02" name="DC.Date" />
      <meta content="Oxford University Press" name="DC.Publisher" />
      <meta content="Davide Mauri" name="DC.Contributor" />
      <meta content="Nicholas Pavlidis" name="DC.Contributor" />
      <meta content="John P. A. Ioannidis" name="DC.Contributor" />
      <meta content="Journal of the National Cancer Institute"
            name="citation_journal_title" />
      <meta content="JNCI J Natl Cancer Inst" name="citation_journal_abbrev" />
      <meta content="0027-8874" name="citation_issn" />
      <meta content="1460-2105" name="citation_issn" />
      <meta name="citation_author" content="Davide Mauri" />
      <meta name="citation_author" content="Nicholas Pavlidis" />
      <meta name="citation_author" content="John P. A. Ioannidis" />
      <meta content="Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis"
            name="citation_title" />
      <meta content="02/02/2005" name="citation_date" />
      <meta content="97" name="citation_volume" />
      <meta content="3" name="citation_issue" />
      <meta content="188" name="citation_firstpage" />
      <meta content="194" name="citation_lastpage" />
      <meta content="97/3/188" name="citation_id" />
      <meta content="97/3/188" name="citation_id_from_sass_path" />
      <meta content="jnci;97/3/188" name="citation_mjid" />
      <meta content="10.1093/jnci/dji021" name="citation_doi" />
      <meta content="http://jnci.oxfordjournals.org/content/97/3/188.abstract"
            name="citation_abstract_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/97/3/188.full"
            name="citation_fulltext_html_url" />
      <meta content="http://jnci.oxfordjournals.org/content/97/3/188.full.pdf"
            name="citation_pdf_url" />
      <meta content="http://jnci.oxfordjournals.org/content/97/3/188"
            name="citation_public_url" />
      <meta content="15687361" name="citation_pmid" />
      <meta name="citation_section" content="Article" />
      <meta name="robots" content="noarchive,nofollow" />
      <meta name="googlebot" content="noarchive" />
      <link href="/content/97/3/172.short" rel="prev" />
      <link href="/content/97/3/195.short" rel="next" />
      <link rel="stylesheet" type="text/css" media="all" href="/shared/css/hw-global.css" />
      <link rel="stylesheet" type="text/css" media="print" href="/shared/css/hw-print.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/local/css/hw-local-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-global.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-ac.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-page-content.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/jquery.fancybox-1.3.4.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/shared/css/hw-global-colexpand.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/publisher/css/hw-publisher-page-content.css" /><script type="text/javascript" id="session-d29421876e1">var callbackToken='53720CA2D9A6650';</script><script type="text/javascript" id="session-d29421876e3">
                      var subCode='oupjournal_sub';
                    </script><script type="text/javascript">
            var gAuthTimeStamp = '2015-10-27T12:14:32.976-07:00';
            var gSessionId = 'kt249Vv7pA6Ulh4t807J3Q';
            var gAuthzRequired = 'false';
            var gAuthnMethods1 = 'ip ip';
            var gAuthnMethods2 = 'ip,ip';
            var gAuthnIPs = '18.189.59.169,18.189.59.169';
            var gAuthnIndividuals = '';
            var gAuthnInstitutions = '10005282,10072538,10328193,100274300,10082403,05094000,10093227,153074108,10080507,21879000,10095822,10081742,10082405,10004595,10019502,10082401,07635000,10082404,06602000';
            </script><script type="text/javascript" src="/shared/js/jquery-min.js"></script><script type="text/javascript" src="/shared/js/fingerprint.js"></script><script type="text/javascript" src="/shared/js/hw-shared.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-site.js"></script><script type="text/javascript" src="/local/js/local-js-vars.js"></script><script type="text/javascript" src="/shared/js/pages/hw-content.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="/shared/js/fancybox/jquery.easing-1.3.pack.js"></script><script type="text/javascript"
              src="/shared/js/fancybox/jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="/shared/js/util/content.jquery.addVariantLink.js"></script><script type="text/javascript" src="/shared/js/util/hw-col-expand.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-modalwin-vars.js"></script><script type="text/javascript"
              src="/publisher/js/hw-publisher-article-dynamic-elements.js"></script><script type="text/javascript" src="/publisher/js/hw-publisher-content.js"></script><script type="text/javascript" src="/shared/js/util/hw-mathjax.js"></script><script type="text/x-mathjax-config">
          MathJax.Hub.Config({
              tex2jax: {
                inlineMath: [["$","$"],["\\(","\\)"]],
                processClass: "tex2jax_process|mathjax"
              }
            });
          MathJax.Hub.Queue(function() {
            gColTempResize = true;
            fixColHeights(1);
            gColTempResize = false;
          });
       </script><script type="text/javascript"
              src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script><script type="text/javascript">
	    
	    
	    
	    var siqDOI = encodeURIComponent("10.1093/jnci/dji021");
	    var siqIsOpenAccess = encodeURIComponent("");
	    var siqPubDate = encodeURIComponent("20050202");

	    if (siqDOI.length == 0) {
	        siqDOI = "UNKNOWN";
	    }
	    
	    
		
		
	    if (gAuthnIndividuals.length != 0) {
		if (gAuthnInstitutions.length != 0) {
		    authnEntity = encodeURIComponent(gAuthnIndividuals
		        + ',' + gAuthnInstitutions);
		} else {
		    authnEntity = encodeURIComponent(gAuthnIndividuals);
		}
	    } else {
	        authnEntity = encodeURIComponent(gAuthnInstitutions);
	    }

	    var commonString =
		'authSessionId=' + gSessionId + String.fromCharCode(0x26)
		+ 'authzRequired=' + gAuthzRequired + String.fromCharCode(0x26)
		+ 'authentication_method=' + encodeURIComponent(gAuthnMethods2) + String.fromCharCode(0x26)
		+ 'authnIPs=' + gAuthnIPs + String.fromCharCode(0x26)
		+ 'authnInstitutions=' + authnEntity;

		
		
		
		

	    var gPageId = "pageid-content";
	    var gVariant = "full-text";

	    
		// Not completely done
		var eventType = "full-text";
		var accessType;
		if (siqIsOpenAccess == 'true') {
		    accessType = 'SOA';
		} else {
		    accessType = 'subscription';
		}
		    
		var NTPT_PGEXTRA =
		    commonString + String.fromCharCode(0x26)
		    + 'event_type=' + eventType + String.fromCharCode(0x26)
		    + 'publication_date=' + siqPubDate + String.fromCharCode(0x26)
		    + 'access_type=' + accessType + String.fromCharCode(0x26)
		    + 'doi=' + siqDOI ;
		    
		

	    // alert("NTPT_PGEXTRA is " + NTPT_PGEXTRA);
	</script><link rel="stylesheet" type="text/css" media="all" href="/resource/css/hw20.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-header.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-footer.css" />
      <link rel="stylesheet" type="text/css" media="all"
            href="/resource/css/h20-oup-sidebars.css" />
      <link type="text/css" media="all" rel="stylesheet" href="/site/resource/jnci_h20.css" />
      <link rel="stylesheet" type="text/css" href="/resource/css/print.css" media="print" /><script type="text/javascript" src="/resource/js/main.js"></script><link rel="stylesheet" type="text/css" media="all"
            href="http://oi-underbar.ifactory.com/underbar/css/pf_oiunderbar.css" />
      <link rel="stylesheet" type="text/css" media="screen"
            href="http://gab.cookie.oup.com/aws-cookie/jquery.fancybox-1.3.4_1.css" /><script type="text/javascript" src="/resource/js/oup_ad_size.js"></script></head>
   <body class="general_page journal jnci">
      <div class="hw-gen-page pagetype-content hw-pub-id-article" id="pageid-content"
           itemscope="itemscope"
           itemtype="http://schema.org/ScholarlyArticle">
         <noscript>
            <p>We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of
               cookies. You can change your cookie settings at any time. <a href="http://global.oup.com/cookiepolicy/">Find out more</a></p>
         </noscript>
         
         
         <p class="hide">
            <a href="#content">Skip Navigation</a>
            
         </p>
         
         
         <div id="secondary_nav">
            <strong id="page_logo" title="Oxford Journals"><a href="http://www.oxfordjournals.org/"><span>Oxford Journals</span></a></strong>
            
            <ul>
               <li id="nav_contact_us" title="Contact Us"><a href="http://www.oxfordjournals.org/contact_us.html"><span>Contact Us</span></a></li>
               <li id="nav_my_basket" title="My Basket"><a href="https://secure.oxfordjournals.org/basket.html"><span>My Basket</span></a></li>
               <li id="nav_my_account" title="My Account"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http://www.oxfordjournals.org/service/Register"><span>My 
                        
                        Account</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="header">
            
            <h1 id="page_title" title="JNCI J Natl Cancer Inst"><a href="/"><span>
                     JNCI J Natl Cancer Inst
                     </span></a></h1>
            
         </div>
         
         
         <div id="primary_nav">
            
            <ul>
               <li id="nav_about_this_journal" title="About This Journal">
                  <a href="http://www.oxfordjournals.org/jnci/about.html">
                     
                     <span>About This Journal</span>
                     </a>
                  
               </li>
               <li id="nav_contact_this_journal" title="Contact This Journal"><a href="/cgi/feedback/"><span>Contact This Journal</span></a></li>
               <li id="nav_subscriptions" title="Subscriptions">
                  <a href="http://www.oxfordjournals.org/jnci/access_purchase/buy_online.html">
                     
                     <span>Subscriptions</span>
                     </a>
                  
               </li>
               <li id="nav_current_issue" title="Current"><a href="/content/current"><span>View Current Issue (Volume 107 Issue 10 October 2015)</span></a></li>
               <li id="nav_archive" title="Archive"><a href="/content/by/year"><span>Archive</span></a></li>
               <li id="nav_search" title="Search"><a href="/search"><span>Search</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="user_nav">
            
            <div class="header-ac-elements">
               
               <div id="authstring">
                  
                  <ul>
                     <li class="subscr-ref">Institution:  MIT Libraries</li>
                     <li class="no-left-border">
                        <a href="/login?uri=http%3A%2F%2Fjnci.oxfordjournals.org%2Fcontent%2F97%2F3%2F188.full">
                           Sign In as Personal Subscriber
                           </a>
                        
                     </li>
                  </ul>           
                  
               </div>   
               
            </div>
            
         </div>
         
         
         <ul id="site-breadcrumbs">
            <li class="first"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http%3A%2F%2Fwww.oxfordjournals.org">Oxford Journals</a></li>
            <li><span class="breadcrumb_subjects"><a href="http://www.oxfordjournals.org/subject/medicine/"
                     class="breadcrumb_subject">Medicine &amp; Health</a></span></li>
            <li><a href="/">JNCI J Natl Cancer Inst</a></li>
            <li><a href="/content/97/3.toc">
                  <span xmlns="" class="volume-value">Volume 97</span>
                  <span xmlns="" class="issue-value"> Issue 3</span></a></li>
            <li>Pp. <span class="slug-pages">
                  188-194.
                  </span></li>
         </ul>
         
         
         
         
         <div id="oas_top" class="ad_hidden">
            <iframe id="id_advertframe_top"
                    src="/resource/htmlfiles/advert.html?p=Top&amp;u=jnci.oxfordjournals.org/content/97/3/188.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         <a name="content"></a>
         
         
         <div id="h20_page"></div>
         
         <div id="content-block">
            <div class="article fulltext-view" itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><h1 id="article-title-1" itemprop="headline">Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis</h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li class="contributor" id="contrib-1" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Davide+Mauri&amp;sortspec=date&amp;submit=Submit">Davide Mauri</a></span>, 
                     </li>
                     <li class="contributor" id="contrib-2" itemprop="author" itemscope="itemscope"
                         itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search"
                              href="/search?author1=Nicholas+Pavlidis&amp;sortspec=date&amp;submit=Submit">Nicholas Pavlidis</a></span> and 
                     </li>
                     <li class="last" id="contrib-3"><span class="name"><a class="name-search"
                              href="/search?author1=John+P.+A.+Ioannidis&amp;sortspec=date&amp;submit=Submit">John P. A. Ioannidis</a></span></li>
                  </ol>
                  <ol class="affiliation-list">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address><em>Affiliations of authors:</em> Department of Medical Oncology (DM, NP) and the Clinical Trials and Evidence-Based Medicine Unit, Department of Hygiene and
                           Epidemiology (JPAI), University of Ioannina School of Medicine, Ioannina, Greece; Institute for Clinical Research and Health
                           Policy Studies, Department of Medicine, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA
                           (JPAI)
                        </address>
                     </li>
                  </ol>
                  <ol class="corresp-list">
                     <li class="fn" id="corresp-1"><em>Correspondence to:</em> John P.A. Ioannidis, MD, Chairman, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina
                        45110, Greece (e-mail: <span class="em-link"><span class="em-addr">jioannid{at}cc.uoi.gr</span></span>).
                     </li>
                  </ol>
                  <ul class="history-list">
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="received"
                         hwp:start="2004-08-02"><span class="received-label">Received </span>August 2, 2004.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="rev-recd"
                         hwp:start="2004-10-14"><span class="rev-recd-label">Revision received </span>October 14, 2004.
                     </li>
                     <li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted"
                         hwp:start="2004-11-23"><span class="accepted-label">Accepted </span>November 23, 2004.
                     </li>
                  </ul>
               </div>
               <div class="section abstract" id="abstract-1" itemprop="description">
                  <div class="section-nav">
                     <div class="nav-placeholder"> </div><a href="#sec-1" title="MATERIALS AND METHODS" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Abstract</h2>
                  
                  <p id="p-1"><em>Background:</em> Interest in the use of preoperative systemic treatment in the management of breast cancer has increased because such neoadjuvant
                     therapy appears to reduce the extent of local surgery required. We compared the clinical end points of patients with breast
                     cancer treated preoperatively with systemic therapy (neoadjuvant therapy) and of those treated postoperatively with the same
                     regimen (adjuvant therapy) in a meta-analysis of randomized trials. <em>Methods:</em> We evaluated nine randomized studies, including a total of 3946 patients with breast cancer, that compared neoadjuvant therapy
                     with adjuvant therapy regardless of what additional surgery and/or radiation treatment was used. Fixed and random effects
                     methods were used to combine data. Primary outcomes were death, disease progression, distant disease recurrence, and loco-regional
                     disease recurrence. Secondary outcomes were local response and conservative local treatment. All statistical tests were two-sided.
                     <em>Results:</em> We found no statistically or clinically significant difference between neoadjuvant therapy and adjuvant therapy arms associated
                     with death (summary risk ratio [RR] = 1.00, 95% confidence interval [CI] = 0.90 to 1.12), disease progression (summary RR
                     = 0.99, 95% CI = 0.91 to 1.07), or distant disease recurrence (summary RR = 0.94, 95% CI = 0.83 to 1.06). However, neoadjuvant
                     therapy was statistically significantly associated with an increased risk of loco-regional disease recurrences (RR = 1.22,
                     95% CI = 1.04 to 1.43), compared with adjuvant therapy, especially in trials where more patients in the neoadjuvant, than
                     the adjuvant, arm received radiation therapy without surgery (RR = 1.53, 95% CI = 1.11 to 2.10). Across trials, we observed
                     heterogeneity in the rates of complete clinical response (range = 7%–65%; <em>P</em> for heterogeneity of &lt;.001), pathologic response (range = 4%–29%; <em>P</em> for heterogeneity of &lt;.001), and adoption of conservative local treatment (range = 28%–89% in neoadjuvant arms, <em>P</em> for heterogeneity of &lt;.001). <em>Conclusions:</em> Neoadjuvant therapy was apparently equivalent to adjuvant therapy in terms of survival and overall disease progression. Neoadjuvant
                     therapy, compared with adjuvant therapy, was associated with a statistically significant increased risk of loco-regional recurrence
                     when radiotherapy without surgery was adopted.
                  </p>
                  
               </div>
               <p id="p-2">Non–metastatic breast cancer is increasingly accepted as a systemic disease rather than a local disease, and interest in the
                  use of systemic preoperative therapy (neoadjuvant chemotherapy and endocrine therapy, also known as primary or induction therapy)
                  to treat the early systemic aspects of the disease is, therefore, increasing <em>(<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>)</em>. Systemic neoadjuvant chemotherapy, moreover, may result in local tumor regression or even in a complete pathologic response.
                  Neoadjuvant therapy may also reduce the extent of local surgery required from radical mastectomy to breast-conserving surgery
                  (e.g., quadrantectomy, segmentectomy, or lumpectomy) without jeopardizing patient survival because the extent of local surgery
                  in patients with breast cancer does not appear to influence major patient outcomes, such as survival and disease-free survival
                  <em>(<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>–<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>)</em>.
               </p>
               <p id="p-3">Neoadjuvant therapy has been found to lead to better control of systemic residual disease in results from animal models <em>(<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>–<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>)</em>. Excision of primary tumors in mice leads to the release of serum growth-stimulating factors from the tumors and of malignant
                  cells that can form metastatic foci <em>(<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>)</em>. When therapy with cyclophosphamide, radiation, tamoxifen, or luteinizing hormone-releasing hormone was preoperatively administrated
                  to tumor-carrying mice, both tumor-cell proliferation and the release of growth-stimulating factors into the serum were suppressed,
                  and survival was improved <em>(<a id="xref-ref-5-2" class="xref-bibr" href="#ref-5">5</a>,<a id="xref-ref-7-2" class="xref-bibr" href="#ref-7">7</a>)</em>. Thus, in mice, neoadjuvant therapy appears to be associated with better local and systemic disease control.
               </p>
               <p id="p-4">The same regimens administered as neoadjuvant therapy and adjuvant therapy (i.e., postoperative therapy) have been compared
                  in randomized trials <em>(<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>–<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>)</em>. We used all available evidence from these trials to assess whether neoadjuvant systemic therapy is associated with any advantage
                  compared with the same adjuvant systemic therapy for the treatment of breast cancer. The primary outcomes that we considered
                  included loco-regional disease recurrence, distant disease recurrence, and overall survival; secondary outcomes included local
                  response and the extent of breast surgery required. To address these issues, we performed a meta-analysis of randomized controlled
                  trials that compared the same treatment regimen for breast cancer as neoadjuvant therapy and as adjuvant systemic therapy.
                  We aimed to generate summary estimates, assess the remaining uncertainty, and estimate the between-study heterogeneity for
                  each clinical outcome.
               </p>
               <div class="section" id="sec-1">
                  <div class="section-nav"><a href="#abstract-1" title="Abstract" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-6" title="RESULTS" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>M<span class="sc">ATERIALS AND</span> M<span class="sc">ETHODS</span></h2>
                  
                  
                  <h3>Identification of Randomized Studies</h3>
                  
                  <p id="p-5">We searched MEDLINE and EMBASE by entering the following in the searching algorithm: breast cancer AND (neoadjuvant OR neo-adjuvant
                     OR pre-operative OR preoperative OR induction) AND (clinical trial OR randomized controlled trial OR double-blind OR single-blind
                     OR random OR randomized OR placebo). We also searched the Cochrane Central Register of Controlled Trials for randomized trials
                     that compared neoadjuvant with adjuvant systemic treatment for breast cancer. We set no language restriction. The latest search
                     was done on October 31, 2003. We also hand-searched for the years 1995 through 2003 several oncology journals that publish
                     many randomized trials <em>(<a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a>)</em> to ensure that electronic searches would not miss reports of eligible studies <em>(<a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a>)</em>. The reference list of retrieved papers was further screened for additional publications, and, to minimize publication bias,
                     several investigators in the field were contacted and asked to provide clarifications and, potentially, additional data.
                  </p>
                  
                  
                  
                  <h3>Eligibility Criteria</h3>
                  
                  <p id="p-6">All randomized controlled studies that compared neoadjuvant with adjuvant systemic treatment (chemotherapy or endocrine therapy)
                     for breast cancer, in which the same regimen was given preoperatively to one group and postoperatively to another group, were
                     considered eligible regardless of what additional surgery or radiation treatment was used. We also accepted trials where one
                     arm received exclusively postoperative therapy while the other arm received some cycles of the same regimen preoperatively
                     and some other cycles postoperatively. We included trials regardless of the exact chemotherapeutic or endocrine regimens being
                     used because results in animal models had shown that the beneficial effects of neoadjuvant chemotherapy and endocrine therapy
                     appeared similar for both treatments <em>(<a id="xref-ref-5-3" class="xref-bibr" href="#ref-5">5</a>,<a id="xref-ref-7-3" class="xref-bibr" href="#ref-7">7</a>)</em>. In addition, all regimens try to reduce tumor burden either by killing cells or by blocking their hormonal stimulation and
                     proliferation. The emphasis of the meta-analysis is on the timing of administration of the treatment, not on the specific
                     types of drugs used or drug regimens.
                  </p>
                  
                  <p id="p-7">We excluded meeting abstracts, escalation dose studies, and pseudorandomized trials (e.g., those with alternate allocation
                     of subjects). If other concomitant anticancer nonsurgical treatments were also used (e.g., hormone therapy and radiation therapy),
                     these treatments should not have differed systematically between the two arms. Whenever more than one publication reported
                     results for the same group of patients, we included only the report with the longest follow-up (largest number of events)
                     to avoid duplication of information. Data from interim analyses were included if no further final report was available.
                  </p>
                  
                  
                  
                  <h3>Data Extraction and Outcomes</h3>
                  
                  <p id="p-8">We recorded the following information about each eligible trial: authors' names, journal and year of publication, country
                     of origin of patients, inclusive dates of patient enrollment, number of centers involved, and study design items (including
                     whether there was a description of the mode of randomization, allocation concealment, number of withdrawals per arm, and blinding).
                     We recorded the following information from both arms of each eligible trial: the number of patients randomly assigned to treatment
                     and analyzed per arm, their age, their tumor stage, their menopausal status, regimens used (including type of therapy [endocrine
                     therapy and/or chemotherapy], timing, number of courses for each arm, and additional treatments given to both arms), and number
                     of outcome events per arm.
                  </p>
                  
                  <p id="p-9">Primary outcomes included death (from any cause), disease progression, loco-regional disease recurrence, and distant disease
                     recurrence (metastasis). Disease progression was defined as loco-regional or distant recurrence, occurrence of contralateral
                     cancer, or death. Loco-regional recurrence was defined as recurrence in the ipsilateral breast or in the ipsilateral regional
                     lymph nodes or chest wall.
                  </p>
                  
                  <p id="p-10">Secondary outcomes included the local clinical response to neoadjuvant treatment (three categories: complete versus partial
                     versus none or progressive disease), the pathologic response (complete versus noncomplete) in the neoadjuvant arm, and the
                     surgical approaches adopted (no surgery needed [radiotherapy only], breast-conserving surgery [e.g., lumpectomy or quadrantectomy],
                     or mastectomy) in each arm. After preoperative chemotherapy, the absence of clinical evidence of tumor in the breast was defined
                     as a clinically complete response and a reduction in the clinical tumor size of 50% or more was defined as a partial response.
                     A complete pathologic response was defined as the absence of tumor in the surgical specimen (primary tumor and lymph node
                     metastasis); this response was pertinent only for women who had surgery after neoadjuvant treatment.
                  </p>
                  
                  <p id="p-11">Two investigators (DM, JPAI) extracted the relevant data, and consensus was reached on all outcomes. Whenever information
                     for outcomes was missing, we contacted the primary investigators to obtain additional data and clarifications.
                  </p>
                  
                  
                  
                  <h3>Statistical Analysis</h3>
                  
                  <p id="p-12">For all primary outcomes in each study, we estimated the risk ratio (RR), with its variance and 95% confidence interval (CI).
                     In studies that did not provide explicit accounting of the numbers of events for each arm, we derived the pertinent numbers
                     from the Kaplan-Meier curves presented, from other information available in the published reports, or from communication with
                     primary investigators. For some outcomes in one study <em>(<a id="xref-ref-8-2" class="xref-bibr" href="#ref-8">8</a>),</em> we used hazard ratio estimates and 95% confidence intervals derived from proportional hazards modeling. Hazard ratios may
                     be more appropriate than risk ratios for synthesizing data from time-to-event studies, but these ratios were rarely reported
                     in adequate detail. Heterogeneity between the risk ratios for the same outcome between different studies was assessed by use
                     of the chi-square-based <em>Q</em> statistic <em>(<a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a>)</em>. Data were then combined across studies by the use of general variance methods with fixed and random effects models <em>(<a id="xref-ref-27-2" class="xref-bibr" href="#ref-27">27</a>)</em>. The fixed effects analysis weighted the natural logarithm of each study's risk ratio by the inverse of its variance. The
                     random effects analysis weighted the natural logarithm of each study's risk ratio by the inverse of its variance plus an estimate
                     of the between-study variance in the presence of between-study heterogeneity. In the absence of between-study heterogeneity,
                     fixed and random effects coincide because the between-study variance is zero. For the secondary outcomes, we estimated whether
                     there was statistically significant between-study heterogeneity. When very large between-study heterogeneity was detected,
                     we did not present weighted summary estimates. We also performed subgroup analyses for the primary outcomes on the basis of
                     whether conservative local management (e.g., lumpectomy or quadrantectomy) or radiotherapy only, without surgery, was used
                     more often in the neoadjuvant arm than in the adjuvant arm.
                  </p>
                  
                  <p id="p-13">Finally, for the primary outcomes, we evaluated whether small and large studies might have yielded different results from
                     each other [by use of the Begg-Mazumdar test based on Kendal's tau correlation coefficient <em>(<a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28</a>)</em>] and whether the summary effect size changed considerably over time as more data accumulated [by use of recursive cumulative
                     meta-analysis <em>(<a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a>,<a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">30</a>)</em> and evaluation of Kaplan-Meier plots from individual studies for proportionality of hazards]. Analyses were conducted in
                     Meta-Analyst (Joseph Lau, Boston, MA) and SPSS version 11.0 (SPSS, Inc., Chicago, IL). All statistical tests were two-tailed.
                  </p>
                  
                  
               </div>
               <div class="section" id="sec-6">
                  <div class="section-nav"><a href="#sec-1" title="MATERIALS AND METHODS" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-11" title="DISCUSSION" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>R<span class="sc">ESULTS</span></h2>
                  
                  
                  <h3>Eligible Studies</h3>
                  
                  <p id="p-14">We identified 12 potentially eligible studies <em>(<a id="xref-ref-8-3" class="xref-bibr" href="#ref-8">8</a>–<a id="xref-ref-24-2" class="xref-bibr" href="#ref-24">24</a>)</em> of neoadjuvant versus adjuvant therapy for patients with breast cancer. One study was excluded from the meta-analysis because
                     no peer-reviewed report has been published, although it has been discussed briefly in review articles <em>(<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>–<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a>)</em>. Two more trials <em>(<a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a>,<a id="xref-ref-24-3" class="xref-bibr" href="#ref-24">24</a>)</em> are ongoing, and no peer-reviewed report has been appeared for either.
                  </p>
                  
                  <p id="p-15">Nine trials were thus eligible, as shown in <a id="xref-table-wrap-1-1" class="xref-table" href="#T1">Table 1</a> <em>(<a id="xref-ref-8-4" class="xref-bibr" href="#ref-8">8</a>–<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>)</em>. A total of 3946 patients were randomly assigned to treatment (1972 in neoadjuvant arms and 1974 in adjuvant arms), and we
                     analyzed data from 3861 of them in this study (1933 and 1928 in the two arms, respectively). In four trials <em>(<a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>–<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>),</em> a total of 85 patients did not have analyzable data. The mean or median age ranged between 43 years and 56 years across the
                     arms of the included trials. There was considerable variability across studies in the eligible stages of breast cancer, tumor
                     size, and lymph node status (<a id="xref-table-wrap-1-2" class="xref-table" href="#T1">Table 1</a>). With the exception of one trial <em>(<a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>)</em> that included only premenopausal patients, all trials included both premenopausal and postmenopausal patients. Many regimens
                     were used (<a id="xref-table-wrap-1-3" class="xref-table" href="#T1">Table 1</a>). The total number of treatment courses in the adjuvant treatment arms varied between four and eight, but the neoadjuvant
                     courses varied between one and six. In four trials <em>(<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>,<a id="xref-ref-12-2" class="xref-bibr" href="#ref-12">12</a>,<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>,<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>),</em> patients in the neoadjuvant arm received some of the courses before surgery and some after surgery. In the other five trials,
                     patients in the neoadjuvant arm received all courses before surgery. All nine trials enrolled patients between January 1983
                     and May 1999. Three of the nine trials were multicentric trials <em>(<a id="xref-ref-8-5" class="xref-bibr" href="#ref-8">8</a>,<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>,<a id="xref-ref-19-2" class="xref-bibr" href="#ref-19">19</a>)</em>.
                  </p>
                  <div class="table pos-float" id="T1">
                     <div class="table-inline">
                        <div class="callout"><span>View this table:</span><ul class="callout-links">
                              <li><a href="188/T1.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="188/T1.expansion.html">In a new window</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="table-caption"><span class="table-label"><strong>Table 1.</strong> </span> 
                        <p id="p-16" class="first-child">Characteristics of eligible trials for this meta-analysis*</p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  
                  <p id="p-20">Only one trial <em>(<a id="xref-ref-11-3" class="xref-bibr" href="#ref-11">11</a>)</em> described in detail the mode of randomization, and three trials <em>(<a id="xref-ref-8-7" class="xref-bibr" href="#ref-8">8</a>,<a id="xref-ref-18-3" class="xref-bibr" href="#ref-18">18</a>,<a id="xref-ref-19-4" class="xref-bibr" href="#ref-19">19</a>)</em> described the mode of allocation concealment in detail. Withdrawals were described in detail in seven trials <em>(<a id="xref-ref-8-8" class="xref-bibr" href="#ref-8">8</a>,<a id="xref-ref-9-2" class="xref-bibr" href="#ref-9">9</a>,<a id="xref-ref-12-4" class="xref-bibr" href="#ref-12">12</a>–<a id="xref-ref-17-3" class="xref-bibr" href="#ref-17">17</a>,<a id="xref-ref-19-5" class="xref-bibr" href="#ref-19">19</a>)</em>. None of the nine studies was blinded. The definition of loco-regional recurrence was similar across studies. However, three
                     studies <em>(<a id="xref-ref-15-3" class="xref-bibr" href="#ref-15">15</a>,<a id="xref-ref-18-4" class="xref-bibr" href="#ref-18">18</a>,<a id="xref-ref-19-6" class="xref-bibr" href="#ref-19">19</a>)</em> did not provide detailed definitions for this outcome but simply separated it from systemic, distant, or metastatic recurrence
                     or relapse without further specification. Complete pathologic response (no invasive tumor cells) was defined similarly in
                     all studies in which it was analyzed <em>(<a id="xref-ref-8-9" class="xref-bibr" href="#ref-8">8</a>,<a id="xref-ref-11-4" class="xref-bibr" href="#ref-11">11</a>,<a id="xref-ref-15-4" class="xref-bibr" href="#ref-15">15</a>,<a id="xref-ref-16-3" class="xref-bibr" href="#ref-16">16</a>,<a id="xref-ref-17-4" class="xref-bibr" href="#ref-17">17</a>,<a id="xref-ref-19-7" class="xref-bibr" href="#ref-19">19</a>)</em>.
                  </p>
                  
                  
                  
                  <h3>Meta-Analysis: Primary Outcomes</h3>
                  
                  <p id="p-21">In the meta-analysis, we included data on 966 deaths from all nine trials <em>(<a id="xref-ref-8-10" class="xref-bibr" href="#ref-8">8</a>–<a id="xref-ref-19-8" class="xref-bibr" href="#ref-19">19</a>)</em>, on 1310 occurrences of disease progression from seven trials <em>(<a id="xref-ref-8-11" class="xref-bibr" href="#ref-8">8</a>–<a id="xref-ref-11-5" class="xref-bibr" href="#ref-11">11</a>,<a id="xref-ref-13-3" class="xref-bibr" href="#ref-13">13</a>–<a id="xref-ref-17-5" class="xref-bibr" href="#ref-17">17</a>, <a id="xref-ref-19-9" class="xref-bibr" href="#ref-19">19</a>),</em> on 520 loco-regional recurrences from all nine trials <em>(<a id="xref-ref-8-12" class="xref-bibr" href="#ref-8">8</a>–<a id="xref-ref-19-10" class="xref-bibr" href="#ref-19">19</a>),</em> and on 745 distant recurrences from seven trials <em>(<a id="xref-ref-9-3" class="xref-bibr" href="#ref-9">9</a>–<a id="xref-ref-11-6" class="xref-bibr" href="#ref-11">11</a>,<a id="xref-ref-13-4" class="xref-bibr" href="#ref-13">13</a>–<a id="xref-ref-19-11" class="xref-bibr" href="#ref-19">19</a>)</em>. Although we contacted the authors, additional data could not be retrieved on disease progression from two trials <em>(<a id="xref-ref-12-5" class="xref-bibr" href="#ref-12">12</a>,<a id="xref-ref-18-5" class="xref-bibr" href="#ref-18">18</a>)</em> and on distant recurrences from two trials <em>(<a id="xref-ref-8-13" class="xref-bibr" href="#ref-8">8</a>,<a id="xref-ref-12-6" class="xref-bibr" href="#ref-12">12</a>)</em>.
                  </p>
                  
                  <p id="p-22">We first used a fixed effects analysis to investigate differences between the compared arms for the outcomes death, disease
                     progression, distant recurrences, and loco-regional recurrences. We found no difference between the arms for the outcomes
                     death (summary RR for death = 1.00, 95% CI = 0.90 to 1.12), disease progression (summary RR for disease progression = 0.99,
                     95% CI = 0.91 to 1.07), and distant recurrences (summary RR for distant recurrence = 0.94, 95% CI = 0.83 to 1.06). However,
                     we did find a statistically significant 22% increased relative risk for loco-regional recurrences associated with neoadjuvant
                     treatment (summary RR for loco-regional recurrence = 1.22, 95% CI = 1.04 to 1.43; <em>P</em> = .015) (<a id="xref-fig-1-1" class="xref-fig" href="#F1">Fig. 1</a>). No statistically significant between-study heterogeneity was observed for any of the four primary outcomes.
                  </p>
                  <div id="F1" class="fig pos-float odd">
                     <div class="fig-inline"><a href="188/F1.expansion.html"><img alt="Fig. 1." src="188/F1.small.gif" /></a><div class="callout"><span>View larger version:</span><ul class="callout-links">
                              <li><a href="188/F1.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="188/F1.expansion.html">In a new window</a></li>
                           </ul>
                           <ul class="fig-services">
                              <li class="ppt-link"><a href="/powerpoint/97/3/188/F1">Download as PowerPoint Slide</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="fig-caption"><span class="fig-label"><strong>Fig. 1.</strong></span> 
                        <p id="p-23" class="first-child">Meta-analysis for primary outcomes with neoadjuvant therapy compared with adjuvant therapy for breast cancer. In each panel,
                           each study [Van der Hage et al. <em>(<a id="xref-ref-8-14" class="xref-bibr" href="#ref-8">8</a>)</em>, Avril et al./Mauriac et al. <em>(<a id="xref-ref-9-4" class="xref-bibr" href="#ref-9">9</a>,<a id="xref-ref-10-2" class="xref-bibr" href="#ref-10">10</a>)</em>, Semiglazov et al. <em>(<a id="xref-ref-11-7" class="xref-bibr" href="#ref-11">11</a>)</em>, Scholl et al. <em>(<a id="xref-ref-12-7" class="xref-bibr" href="#ref-12">12</a>)</em>, Scholl et al. <em>(<a id="xref-ref-13-5" class="xref-bibr" href="#ref-13">13</a>)</em>, Broet et al. <em>(<a id="xref-ref-14-2" class="xref-bibr" href="#ref-14">14</a>)</em>, Makris et al. <em>(<a id="xref-ref-15-5" class="xref-bibr" href="#ref-15">15</a>)</em>, NSABP B-18 <em>(<a id="xref-ref-16-4" class="xref-bibr" href="#ref-16">16</a>,<a id="xref-ref-17-6" class="xref-bibr" href="#ref-17">17</a>)</em>, Gazet et al. <em>(<a id="xref-ref-18-6" class="xref-bibr" href="#ref-18">18</a>)</em>, Danforth et al. <em>(<a id="xref-ref-19-12" class="xref-bibr" href="#ref-19">19</a>)</em>] is shown by the point estimate of the risk ratio (square proportional to the weight of each study) and 95% confidence interval
                           (CI) for the risk ratio (extending lines); the summary risk ratio (ALL) and 95% confidence intervals by fixed effects calculations
                           are also shown by diamonds. For all panels, values greater than 1 indicate that neoadjuvant treatment has a worse outcome
                           compared with adjuvant treatment. (A) Death. (B) Disease progression. (C) Distant disease recurrence. (D) Loco-regional disease
                           recurrence. Arrow = 95% confidence interval extends beyond the depicted range.
                        </p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  
                  <p id="p-24">With a random effects analysis, we found no difference between arms compared for death and distant recurrences; in fact, the
                     results calculated from the random effects analysis were identical to those obtained by fixed effects analysis (between-study
                     variance = 0). Furthermore, the results for disease progression (summary RR = 0.99, 95% CI = 0.88 to 1.11) and loco-regional
                     recurrence (summary RR = 1.22, 95% CI = 1.03 to 1.44; <em>P</em> = .018) were very similar to the results for the same outcomes from the fixed effects analysis. The difference in the results
                     for loco-regional recurrences in the neoadjuvant treatment arms was less than 5% in seven trials <em>(<a id="xref-ref-8-15" class="xref-bibr" href="#ref-8">8</a>,<a id="xref-ref-11-8" class="xref-bibr" href="#ref-11">11</a>,<a id="xref-ref-12-8" class="xref-bibr" href="#ref-12">12</a>,<a id="xref-ref-15-6" class="xref-bibr" href="#ref-15">15</a>–<a id="xref-ref-19-13" class="xref-bibr" href="#ref-19">19</a>),</em> 16.1% in Avril et al. <em>(<a id="xref-ref-9-5" class="xref-bibr" href="#ref-9">9</a>),</em> and 5.6% in Broet et al. <em>(<a id="xref-ref-14-3" class="xref-bibr" href="#ref-14">14</a>)</em>.
                  </p>
                  
                  
                  
                  <h3>Secondary Outcomes</h3>
                  
                  <p id="p-25">Secondary outcomes are shown in <a id="xref-table-wrap-2-1" class="xref-table" href="#T2">Table 2</a>. The rates of complete clinical response were statistically significantly heterogeneous (ranging from 7% to 65%, <em>P</em> for heterogeneity of &lt;.001) across studies. When both complete and partial clinical responses were considered, the difference
                     between extremes was smaller, but the rates were still statistically significantly heterogeneous (ranging from 45% to 83%,
                     <em>P</em> for heterogeneity of &lt;.001). Rates of pathologic response were available in five trials <em>(<a id="xref-ref-8-16" class="xref-bibr" href="#ref-8">8</a>,<a id="xref-ref-11-9" class="xref-bibr" href="#ref-11">11</a>,<a id="xref-ref-15-7" class="xref-bibr" href="#ref-15">15</a>–<a id="xref-ref-17-7" class="xref-bibr" href="#ref-17">17</a>, <a id="xref-ref-19-14" class="xref-bibr" href="#ref-19">19</a>)</em> and were generally low but were still statistically significantly heterogeneous between studies (ranging from 4% to 29%,
                     <em>P</em> for heterogeneity of &lt;.001). In the other four trials <em>(<a id="xref-ref-9-6" class="xref-bibr" href="#ref-9">9</a>,<a id="xref-ref-10-3" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-12-9" class="xref-bibr" href="#ref-12">12</a>–<a id="xref-ref-14-4" class="xref-bibr" href="#ref-14">14</a>,<a id="xref-ref-18-7" class="xref-bibr" href="#ref-18">18</a>),</em> pathologic response rates were not available because radiotherapy was administered to patients who had a complete clinical
                     response. Although the rates of pathologic response were not reported, these rates, by definition, would have been lower than
                     the rates of complete clinical response. Thus, the rates of pathologic response in these four trials should not have exceeded
                     the rates observed in the other trials and should have been lower than those.
                  </p>
                  <div class="table pos-float" id="T2">
                     <div class="table-inline">
                        <div class="callout"><span>View this table:</span><ul class="callout-links">
                              <li><a href="188/T2.expansion.html">In this window</a></li>
                              <li><a class="in-nw" href="188/T2.expansion.html">In a new window</a></li>
                           </ul>
                        </div>
                     </div>
                     <div class="table-caption"><span class="table-label"><strong>Table 2.</strong> </span> 
                        <p id="p-26" class="first-child">Clinical and pathologic response rates of the studies in this meta-analysis in the neoadjuvant arm and local treatment adopted
                           in each arm*
                        </p>
                        <div class="sb-div caption-clear"></div>
                     </div>
                  </div>
                  
                  <p id="p-32">We found large heterogeneity across studies in the rates of conservative local treatment in the adjuvant arms (ranging from
                     0% to 92%; <em>P</em> for heterogeneity of &lt;.001) and in the neoadjuvant arms (ranging from 28% to 89%; <em>P</em> for heterogeneity of &lt;.001). Overall, we found a statistically significant higher rate of conservative local treatment in
                     the neoadjuvant arms than in the adjuvant arms of five studies <em>(<a id="xref-ref-8-18" class="xref-bibr" href="#ref-8">8</a>,<a id="xref-ref-9-8" class="xref-bibr" href="#ref-9">9</a>–<a id="xref-ref-11-11" class="xref-bibr" href="#ref-11">11</a>,<a id="xref-ref-15-9" class="xref-bibr" href="#ref-15">15</a>–<a id="xref-ref-17-9" class="xref-bibr" href="#ref-17">17</a>)</em>, a borderline difference in another trial (<em>P</em> = .06) <em>(<a id="xref-ref-12-11" class="xref-bibr" href="#ref-12">12</a>),</em> and no difference between arms in three studies <em>(<a id="xref-ref-13-7" class="xref-bibr" href="#ref-13">13</a>,<a id="xref-ref-18-9" class="xref-bibr" href="#ref-18">18</a>,<a id="xref-ref-19-16" class="xref-bibr" href="#ref-19">19</a>)</em>. Finally, we found that radiotherapy only, without surgery, was administered statistically significantly more often in the
                     neoadjuvant arms than in the adjuvant arms in three trials <em>(<a id="xref-ref-9-9" class="xref-bibr" href="#ref-9">9</a>,<a id="xref-ref-10-5" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-13-8" class="xref-bibr" href="#ref-13">13</a>,<a id="xref-ref-18-10" class="xref-bibr" href="#ref-18">18</a>)</em>.
                  </p>
                  
                  <p id="p-33">We found no differences in the primary outcomes between the two arms in the subgroup of studies in which there was an excess
                     rate of conservative local treatment in the neoadjuvant arms (e.g., for loco-regional recurrence, RR by random effects = 1.18,
                     95% CI = 0.91 to 1.52; <em>P</em> = .22; and RR by fixed effects = 1.19, 95% CI = 0.99 to 1.43; <em>P</em> = .063; no statistically significant between-study heterogeneity) and the subgroup of studies without such an excess in the
                     former subgroup (e.g., for loco-regional recurrence, RR by both fixed and random effects = 1.31, 95% CI = 0.95 to 1.81; <em>P</em> = .097). However, increased risk of loco-regional recurrence associated with neoadjuvant treatment was driven largely by
                     the three trials <em>(<a id="xref-ref-9-10" class="xref-bibr" href="#ref-9">9</a>,<a id="xref-ref-10-6" class="xref-bibr" href="#ref-10">10</a>,<a id="xref-ref-13-9" class="xref-bibr" href="#ref-13">13</a>,<a id="xref-ref-18-11" class="xref-bibr" href="#ref-18">18</a>)</em> in which radiotherapy only without surgery was adopted more often in the neoadjuvant than in the adjuvant arms (RR by random
                     effects = 1.53, 95% CI = 1.11 to 2.10; <em>P</em> = .009; and RR by fixed effects = 1.53, 95% CI = 1.17 to 2.00; <em>P</em> =.002; no statistically significant between-study heterogeneity), whereas no association with loco-regional recurrences was
                     found in other trials (RR by both fixed and random effects = 1.10, 95% CI = 0.87 to 1.38; <em>P</em> = .44). The strongest association between neoadjuvant treatment and increased risk of loco-regional recurrence was observed
                     in the study in which the patients in the neoadjuvant arm with a complete clinical response received radiotherapy alone without
                     any surgical treatment <em>(<a id="xref-ref-9-11" class="xref-bibr" href="#ref-9">9</a>,<a id="xref-ref-10-7" class="xref-bibr" href="#ref-10">10</a>)</em>. Patients who were treated only with radiotherapy had statistically significantly higher rates of loco-regional recurrence
                     (20 of 44 patients) than patients who were treated with breast-conserving surgery (nine of 40 patients). Subgroup analyses
                     should be interpreted cautiously because of multiple comparisons.
                  </p>
                  
                  
                  
                  <h3>Potential Bias</h3>
                  
                  <p id="p-34">Small trials did not differ from larger trials in their results for death (<em>P</em> =.46), distant disease recurrence (<em>P</em> = .45), or loco-regional recurrence (<em>P</em> = .84). However, there was an indication that smaller studies, compared with larger studies, had a relatively more favorable
                     comparative overall disease progression associated with neoadjuvant treatment (<em>P</em> = .068) than with adjuvant treatment. The first study <em>(<a id="xref-ref-12-12" class="xref-bibr" href="#ref-12">12</a>)</em> did not show different results for any outcome than later studies <em>(<a id="xref-ref-8-19" class="xref-bibr" href="#ref-8">8</a>–<a id="xref-ref-11-12" class="xref-bibr" href="#ref-11">11</a>,<a id="xref-ref-13-10" class="xref-bibr" href="#ref-13">13</a>,<a id="xref-ref-19-17" class="xref-bibr" href="#ref-19">19</a>),</em> and the summary estimates did not change much as more data accumulated over time (data not shown).
                  </p>
                  
                  
               </div>
               <div class="section" id="sec-11">
                  <div class="section-nav"><a href="#sec-6" title="RESULTS" class="prev-section-link"><span>Previous Section</span></a><a href="#fn-group-1" title="Footnotes" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>D<span class="sc">ISCUSSION</span></h2>
                  
                  <p id="p-35">We found no difference in overall survival, disease progression, and distant disease recurrence between the neoadjuvant treatment
                     arms and the adjuvant treatment arms in a meta-analysis of nine trials with a total of approximately 4000 subjects. Moreover,
                     the cumulative data excluded modest even differences in these outcomes. However, neoadjuvant treatment compared with adjuvant
                     treatment was statistically significantly associated with an increased risk of loco-regional disease recurrence, and the difference
                     was greater in trials in which radiotherapy without any surgery was adopted more commonly in the neoadjuvant arm than in the
                     adjuvant arm. Pathologic response rates were rather low regardless of the regimen used, and rates of conservative local management
                     varied considerably across studies.
                  </p>
                  
                  <p id="p-36">Primary systemic treatment has been accepted as the standard of care in women with locally advanced breast cancer <em>(<a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">31</a>)</em>. Downstaging (i.e., the possibility of breast-conserving surgery for locally advanced breast cancer and for lesions more
                     than 3 cm in diameter) and good cosmetic results are considered important advantages of neoadjuvant treatment. The use of
                     primary systemic treatment for smaller, earlier-stage tumors is less well accepted. No trial included in our meta-analysis
                     had a difference in survival or disease progression between neoadjuvant arms and adjuvant arms. From the results of the largest
                     trial <em>(<a id="xref-ref-16-6" class="xref-bibr" href="#ref-16">16</a>,<a id="xref-ref-17-10" class="xref-bibr" href="#ref-17">17</a>)</em> alone, we could exclude differences of 20%–30% between the compared strategies by taking into account the uncertainty of
                     the observed hazard ratios. In our meta-analysis, we excluded differences of 12% for mortality and differences of 9% for disease
                     progression on the basis of the uncertainty of the observed summary risk ratios, thus narrowing the potential for differences
                     of any importance between the two arms. Overall survival is not influenced by the timing of chemotherapy (before or after
                     surgery) but is more likely to be influenced by the chemosensitivity of the primary lesion <em>(<a id="xref-ref-32-1" class="xref-bibr" href="#ref-32">32</a>–<a id="xref-ref-34-1" class="xref-bibr" href="#ref-34">34</a>)</em>. Thus, this meta-analysis did not confirm that neoadjuvant systemic therapy was associated with better clinical outcomes
                     than adjuvant systemic therapy.
                  </p>
                  
                  <p id="p-37">In fact, we found that a statistically significantly higher relative risk of loco-regional disease recurrence was associated
                     with neoadjuvant treatment than with adjuvant treatment. We found no clear association between the risk of loco-regional recurrence
                     and the use of breast-conserving surgery, although data from individuals are required to address this issue more appropriately.
                     Large trials <em>(<a id="xref-ref-2-2" class="xref-bibr" href="#ref-2">2</a>,<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>)</em> have found a higher risk of loco-regional disease recurrence associated with breast-conserving surgery than with more extensive
                     surgical approaches. We found, however, that the increased risk in the neoadjuvant arm largely reflected the use of radiotherapy
                     without any surgery for patients who had an apparently complete clinical response. The loco-regional recurrence problem is
                     compatible with the low rates of complete pathologic response that we observed in these trials. Similarly, low rates of pathologic
                     response (&lt;20%) have also been obtained in trials comparing various neoadjuvant regimens with each other <em>(<a id="xref-ref-35-1" class="xref-bibr" href="#ref-35">35</a>,<a id="xref-ref-36-1" class="xref-bibr" href="#ref-36">36</a>)</em>. The lack of pathologic response appears to be associated with an adverse outcome in the neoadjuvant arms <em>(<a id="xref-ref-16-7" class="xref-bibr" href="#ref-16">16</a>,<a id="xref-ref-37-1" class="xref-bibr" href="#ref-37">37</a>)</em>. Consequently, despite gross clinical response, the tumor bed may not be free of malignant cells, and tumor cell foci may
                     be present in the majority of patients, increasing the risk for subsequent loco-regional disease recurrence. This problem
                     is probably more important when radiotherapy alone is used. An alternative explanation may be that these women would have
                     more breast tissue in which to develop a loco-regional recurrence.
                  </p>
                  
                  <p id="p-38">Our meta-analysis has some limitations. We found some evidence that small trials gave different results from larger trials
                     for disease progression, and publication bias cannot be totally excluded. We have to acknowledge that the meta-analysis is
                     based on data from trials that have published results in the literature. Use of updated individual patient data may further
                     enhance the accuracy and reduce the uncertainty of the estimates <em>(<a id="xref-ref-38-1" class="xref-bibr" href="#ref-38">38</a>,<a id="xref-ref-39-1" class="xref-bibr" href="#ref-39">39</a>)</em>. However, we made an effort to include all additional information that we could obtain from the primary investigators, and
                     definitions for the major outcomes were largely consistent across studies. A meta-analysis of individual-level data may still
                     be performed with an emphasis on identifying patients who have different risks for the major outcomes <em>(<a id="xref-ref-40-1" class="xref-bibr" href="#ref-40">40</a>)</em>. Another potential limitation is that the results of at least two recently launched randomized studies <em>(<a id="xref-ref-23-2" class="xref-bibr" href="#ref-23">23</a>,<a id="xref-ref-24-4" class="xref-bibr" href="#ref-24">24</a>)</em> with a total of 1315 patients were not available to include in the meta-analysis. However, given the accumulated evidence
                     to-date, the overall summary estimates for the primary outcomes that we considered are unlikely to change.
                  </p>
                  
                  <p id="p-39">Another limitation of this study is that there was considerable heterogeneity in the design, modes of treatment used in each
                     study, and response rates. Heterogeneity is not necessarily a disadvantage in meta-analysis <em>(<a id="xref-ref-41-1" class="xref-bibr" href="#ref-41">41</a>)</em>, and in our study, it provided an opportunity to probe the consistency of the treatment effects across the various local
                     treatment approaches used. In particular, there was large variability in the treatment regimens used across these studies,
                     and a meta-analysis for specific regimens would not be feasible. We initially hypothesized, on the basis of results from animal
                     studies and a commonly postulated mechanism, that the relative merits of neoadjuvant and adjuvant therapies do not differ
                     by the regimen used. This potential limitation should be considered seriously. In the meta-analysis, we found no evidence
                     of between-study heterogeneity for any primary outcome despite this variability in treatments. Thus, from the available data,
                     we cannot reject the hypothesis that the specific treatment regimen does not influence the relative merits of neoadjuvant
                     therapy compared with adjuvant therapy. It may be argued, however, that the effect sizes from this meta-analysis should not
                     be extrapolated necessarily to agents with much higher potency or very different modes of action. For example, some recent
                     studies suggest that regimens involving taxanes and/or the monoclonal antibody trastuzumab may be particularly effective as
                     neoadjuvant regimens <em>(<a id="xref-ref-42-1" class="xref-bibr" href="#ref-42">42</a>–<a id="xref-ref-44-1" class="xref-bibr" href="#ref-44">44</a>)</em>. However, none of these regimens have been evaluated in randomized trials that compared neodjuvant therapy with adjuvant
                     therapy.
                  </p>
                  
                  <p id="p-40">Despite these caveats, this meta-analysis demonstrates the equivalence of neoadjuvant and adjuvant treatments for breast cancer
                     in terms of survival, disease progression, and distant recurrence and shows that an increased risk of loco-regional disease
                     recurrence is associated with neoadjuvant treatment, especially when primary systemic treatment is not accompanied by any
                     surgical intervention (i.e., radiation therapy alone). Consequently, we recommend avoiding the use of radiotherapy without
                     any surgical treatment, even in the presence of an apparently good clinical response to neoadjuvant chemotherapy. Some sort
                     of breast-conserving surgical intervention is likely to be warranted, regardless of whether neoadjuvant or adjuvant treatment
                     is adopted and regardless of the patient's initial clinical response.
                  </p>
                  
               </div>
               <div class="section fn-group" id="fn-group-1">
                  <div class="section-nav"><a href="#sec-11" title="DISCUSSION" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="References" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Footnotes</h2>
                  <ul>
                     <li class="fn" id="fn-9">
                        
                        <p id="p-41">We are thankful to Drs. V.F. Semiglazov and L. Mauriac for contributing clarifications for their studies.</p>
                        
                     </li>
                  </ul>
               </div>
               <ul>
                  <li class="fn" id="copyright-statement-1"><em>Journal of the National Cancer Institute,</em> Vol. 97, No. 3, © Oxford University Press 2005, all rights reserved.
                  </li>
               </ul>
               <div class="section ref-list" id="ref-list-1">
                  <div class="section-nav"><a href="#fn-group-1" title="Footnotes" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder"> </div>
                  </div>
                  <h2>References</h2>
                  <ol class="cit-list ref-use-labels">
                     <li><span class="ref-label">(1)</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference (1) in text"
                           id="ref-1">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.1" data-doi="10.1002/cncr.11603">
                           <div class="cit-metadata"><cite>Buchholz TA, Hunt KK, Whitman GJ, Sahin AA, Hortobagyi GN. Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary
                                 considerations of benefits and risks. <span class="cit-source">Cancer</span> <span class="cit-pub-date">2003</span>;<span class="cit-vol">98</span>:<span class="cit-fpage">1150</span>–60.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/cncr.11603&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12973838&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000185276800006&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(2)</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference (2) in text"
                           id="ref-2">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.2"
                             data-doi="10.1056/NEJMoa020989">
                           <div class="cit-metadata"><cite>Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing
                                 breast-conserving surgery with radical mastectomy for early breast cancer. <span class="cit-source">N Engl J Med</span> <span class="cit-pub-date">2002</span>;<span class="cit-vol">347</span>:<span class="cit-fpage">1227</span>–32.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1056/NEJMoa020989&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12393819&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000178598300003&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(3)</span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference (3) in text"
                           id="ref-3">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.3"
                             data-doi="10.1056/NEJMoa022152">
                           <div class="cit-metadata"><cite>Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing
                                 total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. <span class="cit-source">N Engl J Med</span> <span class="cit-pub-date">2002</span>;<span class="cit-vol">347</span>:<span class="cit-fpage">1233</span>–41.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1056/NEJMoa022152&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12393820&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000178598300004&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(4)</span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference (4) in text"
                           id="ref-4">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.4"
                             data-doi="10.1056/NEJMoa020128">
                           <div class="cit-metadata"><cite>Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N, et al. Twenty-five-year follow-up of a randomized trial comparing
                                 radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. <span class="cit-source">N Engl J Med</span> <span class="cit-pub-date">2002</span>;<span class="cit-vol">347</span>:<span class="cit-fpage">567</span>–75.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1056/NEJMoa020128&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12192016&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000177675400005&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(5)</span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference (5) in text"
                           id="ref-5">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.5">
                           <div class="cit-metadata"><cite>Fisher B, Gunduz N, Saffer EA. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth
                                 of metastases. <span class="cit-source">Cancer Res</span> <span class="cit-pub-date">1983</span>;<span class="cit-vol">43</span>:<span class="cit-fpage">1488</span>–92.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=43/4/1488"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(6)</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference (6) in text"
                           id="ref-6">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.6">
                           <div class="cit-metadata"><cite>Fisher B, Gunduz N, Coyle J, Rudock C, Saffer E. Presence of a growth-stimulating factor in serum following primary tumor
                                 removal in mice. <span class="cit-source">Cancer Res</span> <span class="cit-pub-date">1989</span>;<span class="cit-vol">49</span>:<span class="cit-fpage">1996</span>–2001.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=49/8/1996"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(7)</span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference (7) in text"
                           id="ref-7">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.7">
                           <div class="cit-metadata"><cite>Fisher B, Saffer E, Rudock C, Coyle J, Gunduz N. Effect of local or systemic treatment prior to primary tumor removal on the
                                 production and response to a serum growth-stimulating factor in mice. <span class="cit-source">Cancer Res</span> <span class="cit-pub-date">1989</span>;<span class="cit-vol">49</span>:<span class="cit-fpage">2002</span>–4.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=canres&amp;resid=49/8/2002"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(8)</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference (8) in text"
                           id="ref-8">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.8">
                           <div class="cit-metadata"><cite>van der Hage JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L. Preoperative chemotherapy in primary
                                 operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. <span class="cit-source">J Clin Oncol</span> <span class="cit-pub-date">2001</span>;<span class="cit-vol">19</span>:<span class="cit-fpage">4224</span>–37.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=19/22/4224"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(9)</span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference (9) in text"
                           id="ref-9">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.9"
                             data-doi="10.1016/S0001-4001(98)80116-5">
                           <div class="cit-metadata"><cite>Avril A, Faucher A, Bussieres E, Stockle E, Durand M, Mauriac L, et al. Results of 10 years of a randomized trial of neoadjuvant
                                 chemotherapy in breast cancers larger than 3 cm. <span class="cit-source">Chirurgie</span> <span class="cit-pub-date">1998</span>;<span class="cit-vol">123</span>:<span class="cit-fpage">247</span>–56. [In French.]</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0001-4001(98)80116-5&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9752515&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(10)</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference (10) in text"
                           id="ref-10">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.10">
                           <div class="cit-metadata"><cite>Mauriac L, MacGrogan G, Avril A, Durand M, Floquet A, Debled M, et al. Neoadjuvant chemotherapy for operable breast carcinoma
                                 larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS).
                                 <span class="cit-source">Ann Oncol</span> <span class="cit-pub-date">1999</span>;<span class="cit-vol">10</span>:<span class="cit-fpage">47</span>–52.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=10/1/47"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(11)</span><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference (11) in text"
                           id="ref-11">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.11">
                           <div class="cit-metadata"><cite>Semiglazov VF, Topuzov EE, Bavli JL, Moiseyenko VM, Ivanova OA, Seleznev IK, et al. Primary (neoadjuvant) chemotherapy and
                                 radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer. <span class="cit-source">Ann Oncol</span> <span class="cit-pub-date">1994</span>;<span class="cit-vol">5</span>:<span class="cit-fpage">591</span>–5.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=5/7/591"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(12)</span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference (12) in text"
                           id="ref-12">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.12">
                           <div class="cit-metadata"><cite>Scholl SM, Asselain B, Palangie T, Dorval T, Jouve M, Garcia Giralt E, et al. Neoadjuvant chemotherapy in operable breast
                                 cancer. <span class="cit-source">Eur J Cancer</span> <span class="cit-pub-date">1991</span>;<span class="cit-vol">27</span>:<span class="cit-fpage">1668</span>–71.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=1782080&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1991GY58700036&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(13)</span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference (13) in text"
                           id="ref-13">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.13"
                             data-doi="10.1016/0959-8049(94)90537-1">
                           <div class="cit-metadata"><cite>Scholl SM, Fourquet A, Asselain B, Pierga JY, Vilcoq JR, Durand JC, et al. Neoadjuvant versus adjuvant chemotherapy in premenopausal
                                 patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6. <span class="cit-source">Eur J Cancer</span> <span class="cit-pub-date">1994</span>;<span class="cit-vol">30A</span>:<span class="cit-fpage">645</span>–52.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/0959-8049(94)90537-1&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=8080680&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1994NP81300020&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(14)</span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference (14) in text"
                           id="ref-14">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.14"
                             data-doi="10.1023/A:1006339918798">
                           <div class="cit-metadata"><cite>Broet P, Scholl SM, de la Rochefordiere A, Fourquet A, Moreau T, De Rycke Y, et al. Short and long-term effects on survival
                                 in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial. <span class="cit-source">Breast Cancer Res Treat</span> <span class="cit-pub-date">1999</span>;<span class="cit-vol">58</span>:<span class="cit-fpage">151</span>–6.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1023/A:1006339918798&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=10674880&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000084980000009&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(15)</span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference (15) in text"
                           id="ref-15">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.15"
                             data-doi="10.1023/A:1008400706949">
                           <div class="cit-metadata"><cite>Makris A, Powles TJ, Ashley SE, Chang J, Hickish T, Tidy VA, et al. A reduction in the requirements for mastectomy in a randomized
                                 trial of neoadjuvant chemoendocrine therapy in primary breast cancer. <span class="cit-source">Ann Oncol</span> <span class="cit-pub-date">1998</span>;<span class="cit-vol">9</span>:<span class="cit-fpage">1179</span>–84.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=9/11/1179"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(16)</span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference (16) in text"
                           id="ref-16">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.16">
                           <div class="cit-metadata"><cite>Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al. Effect of preoperative chemotherapy on the outcome of
                                 women with operable breast cancer. <span class="cit-source">J Clin Oncol</span> <span class="cit-pub-date">1998</span>;<span class="cit-vol">16</span>:<span class="cit-fpage">2672</span>–85.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=16/8/2672"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(17)</span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference (17) in text"
                           id="ref-17">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.17">
                           <div class="cit-metadata"><cite>Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine-year
                                 results from National Surgical Adjuvant Breast and Bowel Project B-18. <span class="cit-source">J Natl Cancer Inst Monogr</span> <span class="cit-pub-date">2001</span>;<span class="cit-vol">30</span>:<span class="cit-fpage">96</span>–102.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(18)</span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference (18) in text"
                           id="ref-18">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.18"
                             data-doi="10.1023/A:1011115107615">
                           <div class="cit-metadata"><cite>Gazet JC, Ford HT, Gray R, McConkey C, Sutcliffe R, Quilliam J, et al. Estrogen-receptor-directed neoadjuvant therapy for
                                 breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy.
                                 <span class="cit-source">Ann Oncol</span> <span class="cit-pub-date">2001</span>;<span class="cit-vol">12</span>:<span class="cit-fpage">685</span>–91.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=annonc&amp;resid=12/5/685"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(19)</span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference (19) in text"
                           id="ref-19">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.19"
                             data-doi="10.1245/ASO.2003.12.008">
                           <div class="cit-metadata"><cite>Danforth DN Jr, Cowan K, Altemus R, Merino M, Chow C, Berman A, et al. Preoperative FLAC/granulocyte-colony-stimulating factor
                                 chemotherapy for stage II breast cancer: a prospective randomized trial. <span class="cit-source">Ann Surg Oncol</span> <span class="cit-pub-date">2003</span>;<span class="cit-vol">10</span>:<span class="cit-fpage">635</span>–44.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1245/ASO.2003.12.008&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12839848&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000183975200009&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(20)</span><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference (20) in text"
                           id="ref-20">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.20">
                           <div class="cit-metadata"><cite>Ragaz J. Emerging modalities for adjuvant therapy of breast cancer: neoadjuvant chemotherapy. <span class="cit-source">NCI Monogr</span> <span class="cit-pub-date">1986</span>;<span class="cit-vol">1</span>:<span class="cit-fpage">145</span>–52.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(21)</span>
                        
                        
                        <div class="cit ref-cit ref-other no-rev-xref" id="cit-97.3.188.21">
                           <div class="cit-metadata"><cite>Ragaz J. Preoperative (neoadjuvant) chemotherapy for breast cancer: outline of the British Columbia Trial. <span class="cit-source">Recent Results Cancer Res</span> <span class="cit-pub-date">1986</span>;<span class="cit-vol">103</span>:<span class="cit-fpage">85</span>–94.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=3526477&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(22)</span><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference (22) in text"
                           id="ref-22">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.22">
                           <div class="cit-metadata"><cite>Ragaz J, Baird R, Rebbeck P, Coldman A, Goldie J. Neoadjuvant-preoperative-chemotherapy for breast cancer—preliminary report
                                 of the Vancouver trial. <span class="cit-source">Prog Clin Biol Res</span> <span class="cit-pub-date">1985</span>;<span class="cit-vol">201</span>:<span class="cit-fpage">77</span>–87.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=3912768&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(23)</span><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference (23) in text"
                           id="ref-23">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.23">
                           <div class="cit-metadata"><cite>Jakesz R, for ABCSG. Comparison of pre- vs. postoperative chemotherapy in breast cancer patients: Four-years results of Austrian
                                 Breast &amp; Colorectal Cancer Study Group (ABCSG) Trial 7. <span class="cit-source">Proc Am Soc Clin Oncol</span> <span class="cit-pub-date">2001</span>;<span class="cit-vol">20</span>:<span class="cit-fpage">125</span>.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(24)</span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference (24) in text"
                           id="ref-24">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.24">
                           <div class="cit-metadata"><cite>Gianni L, Baselga J, Eiermann W, Porta VG, Semiglazov V, Garcia-Conde J, et al. First report of the European Cooperative Trial
                                 in Operable Breast Cancer (ECTO): Effects of primary systemic therapy (PST) on loco-regional disease. <span class="cit-source">Proc Am Soc Clin Oncol</span> <span class="cit-pub-date">2002</span>;<span class="cit-vol">21</span>:<span class="cit-fpage">34a</span>.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(25)</span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference (25) in text"
                           id="ref-25">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.25"
                             data-doi="10.1016/S0959-8049(02)00239-3">
                           <div class="cit-metadata"><cite>Grossi F, Belvedere O, Rosso R: Geography of clinical cancer research publications from 1995 to 1999. <span class="cit-source">Eur J Cancer</span> <span class="cit-pub-date">2003</span>;<span class="cit-vol">39</span>:<span class="cit-fpage">106</span>–11.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0959-8049(02)00239-3&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12504666&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000181156200016&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(26)</span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference (26) in text"
                           id="ref-26">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.26" data-doi="10.1002/sim.1191">
                           <div class="cit-metadata"><cite>Hopewell S, Clarke M, Lusher A, Lefebvre C, Westby M. A comparison of handsearching versus MEDLINE searching to identify reports
                                 of randomized controlled trials. <span class="cit-source">Stat Med</span> <span class="cit-pub-date">2002</span>;<span class="cit-vol">21</span>:<span class="cit-fpage">1625</span>–34.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1002/sim.1191&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12111923&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000176016900009&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(27)</span><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference (27) in text"
                           id="ref-27">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.27"
                             data-doi="10.7326/0003-4819-127-9-199711010-00008">
                           <div class="cit-metadata"><cite>Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. <span class="cit-source">Ann Intern Med</span> <span class="cit-pub-date">1997</span>;<span class="cit-vol">127</span>:<span class="cit-fpage">820</span>–6.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.7326/0003-4819-127-9-199711010-00008&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9382404&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1997YD89800007&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(28)</span><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference (28) in text"
                           id="ref-28">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.28" data-doi="10.2307/2533446">
                           <div class="cit-metadata"><cite>Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. <span class="cit-source">Biometrics</span> <span class="cit-pub-date">1994</span>;<span class="cit-vol">50</span>:<span class="cit-fpage">1088</span>–101.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.2307/2533446&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=7786990&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1994QP05000016&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(29)</span><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference (29) in text"
                           id="ref-29">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.29"
                             data-doi="10.1016/S0895-4356(98)00159-0">
                           <div class="cit-metadata"><cite>Ioannidis JP, Contopoulos-Ioannidis DG, Lau J. Recursive cumulative meta-analysis: a diagnostic for the evolution of total
                                 randomized evidence from group and individual patient data. <span class="cit-source">J Clin Epidemiol</span> <span class="cit-pub-date">1999</span>;<span class="cit-vol">52</span>:<span class="cit-fpage">281</span>–91.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0895-4356(98)00159-0&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=10235168&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000080058300002&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(30)</span><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference (30) in text"
                           id="ref-30">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.30"
                             data-doi="10.1073/pnas.021529998">
                           <div class="cit-metadata"><cite>Ioannidis J, Lau J. Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses. <span class="cit-source">Proc Natl Acad Sci USA</span> <span class="cit-pub-date">2001</span>;<span class="cit-vol">98</span>:<span class="cit-fpage">831</span>–6.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=pnas&amp;resid=98/3/831"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(31)</span><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference (31) in text"
                           id="ref-31">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.31"
                             data-doi="10.1200/JCO.2003.01.136">
                           <div class="cit-metadata"><cite>Kaufmann M, von Minckwitz G, Smith R, Valero V, Gianni L, Eiermann W, et al. International expert panel on the use of primary
                                 (preoperative) systemic treatment of operable breast cancer: review and recommendations. <span class="cit-source">J Clin Oncol</span> <span class="cit-pub-date">2003</span>;<span class="cit-vol">21</span>:<span class="cit-fpage">2600</span>–8.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=21/13/2600"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(32)</span><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference (32) in text"
                           id="ref-32">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.32"
                             data-doi="10.1016/S0959-8049(02)00732-3">
                           <div class="cit-metadata"><cite>Aas T, Geisler S, Eide GE, Haugen DF, Varhaug JE, Bassoe AM, et al. Predictive value of tumour cell proliferation in locally
                                 advanced breast cancer treated with neoadjuvant chemotherapy. <span class="cit-source">Eur J Cancer</span> <span class="cit-pub-date">2003</span>;<span class="cit-vol">39</span>:<span class="cit-fpage">438</span>–46.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0959-8049(02)00732-3&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=12751373&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000181686800015&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(33)</span>
                        
                        
                        <div class="cit ref-cit ref-other no-rev-xref" id="cit-97.3.188.33"
                             data-doi="10.1016/S0140-6736(05)61752-7">
                           <div class="cit-metadata"><cite>Ellis PA, Smith IE, McCarthy K, Detre S, Salter J, Dowsett M. Preoperative chemotherapy induces apoptosis in early breast
                                 cancer. <span class="cit-source">Lancet</span> <span class="cit-pub-date">1997</span>;<span class="cit-vol">349</span>:<span class="cit-fpage">849</span>.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0140-6736(05)61752-7&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9121265&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=A1997WP40300018&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(34)</span><a class="rev-xref-ref" href="#xref-ref-34-1" title="View reference (34) in text"
                           id="ref-34">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.34"
                             data-doi="10.1023/A:1006194921139">
                           <div class="cit-metadata"><cite>Shao ZM, Li J, Wu J, Han QX, Shen ZZ, Fontana JA, Barsky SH. Neo-adjuvant chemotherapy for operable breast cancer induces
                                 apoptosis. <span class="cit-source">Breast Cancer Res Treat</span> <span class="cit-pub-date">1999</span>;<span class="cit-vol">53</span>:<span class="cit-fpage">263</span>–9.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1023/A:1006194921139&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=10369072&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000080273100007&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(35)</span><a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference (35) in text"
                           id="ref-35">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.35">
                           <div class="cit-metadata"><cite>von Minckwitz G, Raab G, Shutte M, Hilfrich J, Blohmer JU, Gerber B, et al. Dose-dense versus sequential Adriamycin/docetaxel
                                 combination as preoperative chemotheraphy (pCHT) in operable breast cancer (T2–3 N0–2 M0): Primary endpoint analysis of the
                                 GEPARDUO study. <span class="cit-source">Proc Am Soc Clin Oncol</span> <span class="cit-pub-date">2002</span>;<span class="cit-vol">21</span>:<span class="cit-fpage">43a</span>.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(36)</span><a class="rev-xref-ref" href="#xref-ref-36-1" title="View reference (36) in text"
                           id="ref-36">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.36">
                           <div class="cit-metadata"><cite>NSABP: The effect on primary tumor response of adding sequential taxotere to adriamycin and cyclophosphamide: preliminary
                                 results of the NSABP protocol B-27. <span class="cit-source">Breast Canc Res Treat</span> <span class="cit-pub-date">2001</span>;<span class="cit-vol">69</span>:<span class="cit-fpage">210</span>.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(37)</span><a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference (37) in text"
                           id="ref-37">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.37"
                             data-doi="10.1054/bjoc.2000.1461">
                           <div class="cit-metadata"><cite>Pierga JY, Mouret E, Dieras V, Laurence V, Beuzeboc P, Dorval T, et al. Prognostic value of persistent node involvement after
                                 neoadjuvant chemotherapy in patients with operable breast cancer. <span class="cit-source">Br J Cancer</span> <span class="cit-pub-date">2000</span>;<span class="cit-vol">83</span>:<span class="cit-fpage">1480</span>–7.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1054/bjoc.2000.1461&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=11076657&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000165603000014&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(38)</span><a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference (38) in text"
                           id="ref-38">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.38"
                             data-doi="10.1177/0163278702025001006">
                           <div class="cit-metadata"><cite>Stewart LA, Tierney JF. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient
                                 data. <span class="cit-source">Eval Health Prof</span> <span class="cit-pub-date">2002</span>;<span class="cit-vol">25</span>:<span class="cit-fpage">76</span>–97.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=spehp&amp;resid=25/1/76"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(39)</span><a class="rev-xref-ref" href="#xref-ref-39-1" title="View reference (39) in text"
                           id="ref-39">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.39">
                           <div class="cit-metadata"><cite>Clarke M, Stewart L, Pignon JP, Bijnens L. Individual patient data meta-analysis in cancer. <span class="cit-source">Br J Cancer</span> <span class="cit-pub-date">1998</span>;<span class="cit-vol">77</span>:<span class="cit-fpage">2036</span>–44.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=9667689&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000080207600052&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(40)</span><a class="rev-xref-ref" href="#xref-ref-40-1" title="View reference (40) in text"
                           id="ref-40">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.40"
                             data-doi="10.1016/S0895-4356(00)00311-5">
                           <div class="cit-metadata"><cite>Trikalinos TA, Ioannidis JP. Predictive modeling and heterogeneity of baseline risk in meta-analysis of individual patient
                                 data. <span class="cit-source">J Clin Epidemiol</span> <span class="cit-pub-date">2001</span>;<span class="cit-vol">54</span>:<span class="cit-fpage">245</span>–52.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0895-4356(00)00311-5&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=11223322&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000167162300005&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(41)</span><a class="rev-xref-ref" href="#xref-ref-41-1" title="View reference (41) in text"
                           id="ref-41">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.41"
                             data-doi="10.1016/S0140-6736(97)08468-7">
                           <div class="cit-metadata"><cite>Lau J, Ioannidis JP, Schmid CH. Summing up evidence: one answer is not always enough. <span class="cit-source">Lancet</span> <span class="cit-pub-date">1998</span>;<span class="cit-vol">351</span>:<span class="cit-fpage">123</span>–7.</cite></div>
                           <div class="cit-extra"><a href="/external-ref?access_num=10.1016/S0140-6736(97)08468-7&amp;link_type=DOI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="/external-ref?access_num=9439507&amp;link_type=MED"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="/external-ref?access_num=000071591900043&amp;link_type=ISI"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(42)</span><a class="rev-xref-ref" href="#xref-ref-42-1" title="View reference (42) in text"
                           id="ref-42">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.42"
                             data-doi="10.1200/JCO.20.6.1456">
                           <div class="cit-metadata"><cite>Smith IC, Heys SD, Hutcheon AW, Miller ID, Payne S, Gilbert FJ, et al. Neoadjuvant chemotherapy in breast cancer: significantly
                                 enhanced response with docetaxel. <span class="cit-source">J Clin Oncol</span> <span class="cit-pub-date">2002</span>;<span class="cit-vol">20</span>:<span class="cit-fpage">1456</span>–66.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=20/6/1456"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(43)</span>
                        
                        
                        <div class="cit ref-cit ref-other no-rev-xref" id="cit-97.3.188.43"
                             data-doi="10.1200/JCO.2003.12.005">
                           <div class="cit-metadata"><cite>Bear HD, Anderson S, Brown A, Smith R, Mamounas EP, Fisher B, et al. The effect on tumor response of adding sequential preoperative
                                 docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and
                                 Bowel Project Protocol B-27. <span class="cit-source">J Clin Oncol</span> <span class="cit-pub-date">2003</span>;<span class="cit-vol">21</span>:<span class="cit-fpage">4165</span>–74.</cite></div>
                           <div class="cit-extra"><a href="/cgi/ijlink?linkType=ABST&amp;journalCode=jco&amp;resid=21/22/4165"
                                 class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><span class="ref-label">(44)</span><a class="rev-xref-ref" href="#xref-ref-44-1" title="View reference (44) in text"
                           id="ref-44">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-97.3.188.44">
                           <div class="cit-metadata"><cite>Buzdar AU, Hunt K, Smith T, Francis D, Ewer D, Booser E, et al. Significantly higher pathological complete remission (PCR)
                                 rate following neoadjuvant therapy with trastuzumab (H), paclitaxel (P) and antracycline-containing chemotherapy (CT): initial
                                 results of a randomised trial in operable breast cancer (BC) with HER/2 positive disease. New Orleans, LA: Proc ASCO, 2004
                                 June 5–8. <span class="cit-source">Proc Am Soc Clin Oncol</span> <span class="cit-pub-date">2004</span>;<span class="cit-vol">23</span>:<span class="cit-fpage">7</span>.</cite></div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                  </ol>
               </div><span class="highwire-journal-article-marker-end"></span></div>
            <div id="related">
               <h2>Related articles</h2>
               <ul class="related-list">
                  <div class="cit">
                     <div class="cit-metadata"><span class="cit-first-element cit-section">MEMO TO THE MEDIA<span class="cit-sep cit-sep-after-article-section">:</span> </span><ul class="cit-auth-list">
                           <li class="first-item"><span class="cit-auth cit-auth-type-author">Sarah L. Zielinski</span></li>  
                        </ul><span class="cit-title">Press Release<span class="cit-sep cit-sep-after-article-title">: </span><span class="cit-subtitle">Neoadjuvant and Adjuvant Systemic Therapy for Breast Cancer Give Equivalent Survival, Study Finds </span> </span> <cite><abbr title="Journal of the National Cancer Institute" class="site-title">JNCI J Natl Cancer Inst</abbr> <span class="cit-print-date"><span class="cit-sep cit-sep-before-article-print-date">(</span>2005<span class="cit-sep cit-sep-after-article-print-date">)</span> </span><span class="cit-vol">97 </span><span class="cit-issue"><span class="cit-sep cit-sep-before-article-issue">(</span>3<span class="cit-sep cit-sep-after-article-issue">):</span> </span><span class="cit-pages"><span class="cit-first-page">157</span> </span><span class="cit-doi"><span class="cit-sep cit-sep-before-article-doi"> doi:</span>10.1093/jnci/97.3.157-a </span><span class="cit-online-date"><span class="cit-sep cit-sep-before-article-online-date">First published online </span>February 1, 2005 </span></cite>  
                     </div>
                     <div class="cit-extra"><span class="accesscheck jnci;97/3/157-a extract,full"></span> 
                        <ul class="cit-views">
                           <li class="first-item"><a href="/content/97/3/157.1.extract" rel="extract">Extract</a></li>
                           <li class="last-item"><a href="/content/97/3/157.1.full" rel="full-text">Full Text (HTML)</a></li>
                        </ul>  
                     </div> 
                  </div>
               </ul>
            </div><span id="related-urls"></span></div>
         <div id="col-2">
            
            <div class="article-nav sidebar-nav">
               <a href="/content/97/3/172.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="/content/97/3/195.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="/content/97/3.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              <cite>
                                 <abbr title="JNCI Journal of the National Cancer Institute" class="slug-jnl-abbrev">
                                    <nlm:abbrev-journal-title xmlns:nlm="http://schema.highwire.org/NLM/Journal" abbrev-type="publisher">JNCI J Natl Cancer Inst</nlm:abbrev-journal-title></abbr><span class="slug-pub-date" itemprop="datePublished">
                                    (2005) 
                                    </span>
                                 
                                 <span class="slug-vol">
                                    97
                                    </span><span class="slug-issue">
                                    (3):
                                    </span><span class="slug-pages">
                                    188-194.
                                    </span>
                                 <span class="slug-doi-wrapper">
                                    
                                    doi:
                                    
                                    <span title="10.1093/jnci/dji021" class="slug-doi">10.1093/jnci/dji021</span>
                                    </span>
                                 </cite>
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li class="abstract-view-link primary"><a href="/content/97/3/188.abstract" rel="view-abstract">Abstract</a><span class="free">Free</span></li>
                        <li class="notice full-text-view-link"><span class="variant-indicator">» <span>Full Text (HTML)</span></span><span class="free">Free</span></li>
                        <li class="notice full-text-pdf-view-link"><a href="/content/97/3/188.full.pdf+html" rel="view-full-text.pdf">Full Text (PDF)</a><span class="free">Free</span></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><span>Classifications</span></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search"
                                    href="/search?tocsectionid=ARTICLES&amp;sortspec=date&amp;submit=Submit">Article</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><span>Services</span></h4>
                     <ol>
                        <li class="usage-stats-link icon-link"><a href="/articleusage?gca=jnci;97/3/188" rel="nofollow">Article metrics</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=jnci%3B97%2F3%2F188&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/97/3/188.full">Alert me when cited</a></li>
                        <li class="alert-link icon-link"><a href="/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=97/3/188&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jnci.oxfordjournals.org/content/97/3/188.full">Alert me if corrected</a></li>
                        <li class="similar-link"><a href="/search?qbe=jnci%3B97%2F3%2F188&amp;citation=Mauri%20et%20al.%2097%20%283%29:%20188&amp;submit=yes">Find similar articles</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=jnci%3B97%2F3%2F188&amp;link_type=ISI_RELATEDRECORDS"
                              id="cb-isi-similar-articles"
                              class="similar-link">Similar articles in Web of Science</a></li>
                        <li class="similar-link"><a href="/external-ref?access_num=15687361&amp;link_type=MED_NBRS"
                              class="similar-link">Similar articles in PubMed</a></li>
                        <li class="folder-link icon-link"><a href="/cgi/folders?action=addtofolder&amp;wherefrom=JOURNALS&amp;wrapped_id=jnci%3B97%2F3%2F188">Add to my archive</a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="/citmgr?gca=jnci%3B97%2F3%2F188">Download citation</a></li>
                        <li><a class="request-permissions"
                              href="https://s100.copyright.com/AppDispatchServlet?publisherName=oup&amp;publication=jnci&amp;title=Neoadjuvant%20Versus%20Adjuvant%20Systemic%20Treatment%20in%20Breast%20Cancer%3A%20A%20Meta-Analysis%3A%20&amp;publicationDate=02%2F02%2F2005&amp;author=Davide%20Mauri%2C%20Nicholas%20Pavlidis%2C%20John%20P.%20A.%20Ioannidis&amp;copyright=Oxford%20University%20Press&amp;contentID=10.1093%2Fjnci%2Fdji021&amp;volumeNum=97&amp;issueNum=3&amp;startPage=188&amp;endPage=194&amp;orderBeanReset=true"
                              target="_blank">Request Permissions</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-cit">
                     <h4 class="cb-section-header"><span>Citing Articles</span></h4>
                     <ol>
                        <li class="hw-citing-link"><a href="/content/97/3/188.full?cited-by=yes&amp;legid=jnci;97/3/188#cited-by"
                              id="cb-hw-citing-articles">Load citing article information</a></li>
                        <li><a href="/cgi/crossref-forward-links/97/3/188" rel="external-nw"
                              id="cb-crossref-citing-articles">Citing articles via CrossRef</a></li>
                        <li><a href="/scopus-links/jnci/97/3/188?access_num=/jnci/97/3/188" rel="external-nw"
                              id="cb-scopus-citing-articles">Citing articles via Scopus</a></li>
                        <li><a href="/external-ref?access_num=%2Fjnci%2F97%2F3%2F188&amp;link_type=ISI_CITING&amp;accnum_type=native"
                              rel="external-nw"
                              id="cb-isi-citing-articles">Citing articles via Web of Science</a></li>
                        <li><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/97/3/188.abstract&amp;link_type=GOOGLESCHOLAR">Citing articles via Google Scholar</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-gs">
                     <h4 class="cb-section-header"><span>Google Scholar</span></h4>
                     <ol>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3AMauri%20author%3AD.%22"
                              class="cb-art-gs-auth author-link">Articles by  Mauri, D.</a></li>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3AIoannidis%20author%3AJ.P.A.%22"
                              class="cb-art-gs-auth author-link">Articles by  Ioannidis, J. P. A.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="/external-ref?access_num=http://jnci.oxfordjournals.org/content/97/3/188.abstract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-pm">
                     <h4 class="cb-section-header"><span>PubMed</span></h4>
                     <ol>
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="/external-ref?access_num=15687361&amp;link_type=PUBMED"
                              class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Mauri%20D&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Mauri, D.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Pavlidis%20N&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Pavlidis, N.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="/external-ref?access_num=Ioannidis%20JP&amp;link_type=AUTHORSEARCH"
                              class="cb-art-pm-auth author-link">Articles by  Ioannidis, J. P. A.</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible default-closed" id="cb-art-rel">
                     <h4 class="cb-section-header"><span>Related Content</span></h4>
                     <ol>
                        <li><a href="#related">Related articles in this journal</a></li>
                        <li><a href="/content/97/3/188.full?related-urls=yes&amp;legid=jnci;97/3/188#related-urls"
                              id="cb-related-urls">Load related web page information</a></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-soc">
                     <h4 class="cb-section-header"><span>Share</span></h4>
                     <ol>
                        <li><a href="/email?gca=jnci%3B97%2F3%2F188&amp;current-view-path=/content/97/3/188.full">
                              Email this article</a></li>
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/97/3/188&amp;title=Neoadjuvant%20Versus%20Adjuvant%20Systemic%20Treatment%20in%20Breast%20Cancer%3A%20A%20Meta-Analysis+--+Mauri%20et%20al.%2097%20%283%29%3A%20188+--+&amp;doi=10.1093/jnci/dji021&amp;link_type=CITEULIKE"><img src="/shared/img/common/social-bookmarking/citeulike.gif"
                                            alt="Add to CiteULike"
                                            title="CiteULike" /></a><span class="soc-bm-link-text">CiteULike</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/97/3/188&amp;title=Neoadjuvant%20Versus%20Adjuvant%20Systemic%20Treatment%20in%20Breast%20Cancer%3A%20A%20Meta-Analysis+--+Mauri%20et%20al.%2097%20%283%29%3A%20188+--+&amp;doi=10.1093/jnci/dji021&amp;link_type=DEL_ICIO_US"><img src="/shared/img/common/social-bookmarking/delicious.gif"
                                            alt="Add to Delicious"
                                            title="Delicious" /></a><span class="soc-bm-link-text">Delicious</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-facebook"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/short/97/3/188&amp;title=Neoadjuvant%20Versus%20Adjuvant%20Systemic%20Treatment%20in%20Breast%20Cancer%3A%20A%20Meta-Analysis+--+Mauri%20et%20al.%2097%20%283%29%3A%20188+--+&amp;doi=10.1093/jnci/dji021&amp;link_type=FACEBOOK"
                                       class="sb-facebook"
                                       rel="external-nw"><img src="/shared/img/common/social-bookmarking/facebook.gif" alt="Add to Facebook"
                                            title="Facebook" /></a><span class="soc-bm-link-text">Facebook</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-googleplus"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/97/3/188&amp;title=Neoadjuvant%20Versus%20Adjuvant%20Systemic%20Treatment%20in%20Breast%20Cancer%3A%20A%20Meta-Analysis+--+Mauri%20et%20al.%2097%20%283%29%3A%20188+--+&amp;doi=10.1093/jnci/dji021&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="/shared/img/common/social-bookmarking/googleplus.jpg" alt="Add to Google+"
                                            title="Google+" /></a><span class="soc-bm-link-text">Google+</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/97/3/188&amp;title=Neoadjuvant%20Versus%20Adjuvant%20Systemic%20Treatment%20in%20Breast%20Cancer%3A%20A%20Meta-Analysis+--+Mauri%20et%20al.%2097%20%283%29%3A%20188+--+&amp;doi=10.1093/jnci/dji021&amp;link_type=MENDELEY"><img src="/shared/img/common/social-bookmarking/mendeley.gif" alt="Add to Mendeley"
                                            title="Mendeley" /></a><span class="soc-bm-link-text">Mendeley</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="/external-ref?tag_url=http://jnci.oxfordjournals.org/cgi/content/long/97/3/188&amp;title=Neoadjuvant%20Versus%20Adjuvant%20Systemic%20Treatment%20in%20Breast%20Cancer%3A%20A%20Meta-Analysis+--+Mauri%20et%20al.%2097%20%283%29%3A%20188+--+&amp;doi=10.1093/jnci/dji021&amp;link_type=TWITTER"><img src="/shared/img/common/social-bookmarking/twitter.gif" alt="Add to Twitter"
                                            title="Twitter" /></a><span class="soc-bm-link-text">Twitter</span></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#abstract-1">Abstract</a></li>
                        <li><a href="#sec-1">M<span class="sc">ATERIALS AND</span> M<span class="sc">ETHODS</span></a></li>
                        <li><a href="#sec-6">R<span class="sc">ESULTS</span></a></li>
                        <li><a href="#sec-11">D<span class="sc">ISCUSSION</span></a></li>
                        <li><a href="#fn-group-1">Footnotes</a></li>
                        <li><a href="#ref-list-1">References</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            
         </div>
         <div id="col-3">
            
            <div id="col-3-qs" class="sidebar-qs">
               
               
               <form class="searchbox" action="/search" method="get">
                  <p>Search this journal:</p>
                  <div>
                     	
                     	
                     	<input value="" type="text" name="fulltext" id="header-qs-input" />
                     <input type="hidden" name="submit" value="yes" />
                     
                     <input class="inline_button" type="image" alt="Go" src="/publisher/img/buttons/go.gif" />
                     
                     <div class="adv-search-link"><a href="/search">Advanced »</a></div>
                     
                     
                  </div>
               </form>
               
            </div>
            <div class="cb-contents">
               
               <div id="sidebar-current-issue" class="content-box">
                  	
                  <h3 class="cb-contents-header">Current Issue</h3>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           	      <a href="/content/current"><span>
                                 		  <span class="current-issue-date">
                                    October 2015
                                    </span><span class="toc-citation-volume">
                                    
                                    107
                                    </span><span class="toc-citation-issue">(10)</span>
                                 		  
                                 		</span></a>
                           	    
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           <a href="/content/current"><img src="/content/107/10.cover.gif" alt="JNCI J Natl Cancer Inst" id="cover" /></a>
                           
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section sidebar-etoc-link">
                     	  
                     <ol>
                        <li><a href="/cgi/alerts/etoc">Alert me to new issues</a></li>
                     </ol>
                     	
                  </div>
                  
               </div>
               
            </div>
            
            <div id="second">
               
               <div class="ad_hidden" id="oas_right1">
                  <iframe id="id_advertframe_right1"
                          src="/resource/htmlfiles/advert.html?p=Right1&amp;u=jnci.oxfordjournals.org/content/97/3/188.full"
                          width="0"
                          height="0"
                          frameborder="0"
                          scrolling="no"
                          class="resize_ad"></iframe>
                  
               </div>
               
               <div class="features">
                  
                  <div class="feature separator_after first">
                     
                     <h2 id="the_journal" title="The Journal"><span>The Journal</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/about.html" rel=""
                              title="About this journal">About this journal</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/contact_us.html" rel=""
                              title="Contact Us">Contact Us</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/rights_permissions.html"
                              rel=""
                              title="Rights &amp; Permissions">Rights &amp; Permissions</a>
                           
                        </li>
                        <li>
                           <a href="HTTP://www.oxfordjournals.org/access_purchase/dispatch_dates.html#JNCI.JP"
                              rel=""
                              title="Dispatch date of next issue">Dispatch date of next issue</a>
                           
                        </li>
                        <li>
                           <a href="http://publicationethics.org/" rel=""
                              title="This journal is a member of the Committee on Publication Ethics (COPE)">This journal is a member of the Committee on Publication Ethics (COPE)</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/mobile_faqs.html" rel=""
                              title="We are mobile – find out more">We are mobile – find out more</a>
                           
                        </li>
                        <li>
                           <a href="http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;t732=469986&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102"
                              rel=""
                              title="Journals Career Network">Journals Career Network</a>
                           
                        </li>
                     </ul>
                     
                     <p>
                        <a href="http://www.oxfordjournals.org/our_journals/jnci/episodes_2012.html">
                           <img alt="Podcast Logo" style="float:left"
                                src="http://www.oxfordjournals.org/podcasts/podcast_icon_35x35.gif" />JNCI Podcast</a>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Connect with us!</h3>
                     <a href="https://twitter.com/JNCI_Now">
                        <img class="small_margin" alt="Connect with us on Twitter!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/connect_twitter.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     <a href="https://www.facebook.com/thejnci">
                        <img class="small_margin" alt="Connect with us on Facebook!"
                             src="http://www.oxfordjournals.org/our_journals/phisci/facebook.png"
                             style="vertical-align: top; float: left; " />
                        </a>
                     
                     <p>
                        <br />
                        <br />
                        
                     </p>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Editor-in-Chief</h3>
                     
                     <p>Carmen J. Allegra</p>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/editorial_board.html"
                              rel=""
                              title="View full editorial board">View full editorial board</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Impact factor: 12.583</h3>
                     
                     <h3 class="five_year">5-Yr impact factor: 13.584</h3>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h3>For the Media</h3>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/press_room.html" rel=""
                              title="JNCI PRESS ROOM">JNCI PRESS ROOM</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="for_authors" title="For Authors"><span>For Authors</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/our_journals/jnci/for_authors/index.html"
                              rel=""
                              title="Instructions to authors">Instructions to authors</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/self-archiving_policyb.html"
                              rel=""
                              title="Self Archiving/Public Access Policy">Self Archiving/Public Access Policy</a>
                           
                        </li>
                     </ul>
                     <a href="http://www.oxfordjournals.org/oxfordopen/ ">
                        <img alt="Open access options for authors - visit Oxford Open"
                             src="http://www.oxfordjournals.org/resource/image/promos/oxford_open_small.gif" />
                        </a>
                     <a href="http://www.oxfordjournals.org/oxfordopen/funder_policies/">
                        <img alt="RCUK Wellcome Trust Open Access"
                             src="http://www.oxfordjournals.org/resource/image/wellcome-trust-180x100.jpg" />
                        </a>
                     
                     <p>Open access options for authors - visit <a href="http://www.oxfordjournals.org/oxfordopen/">Oxford Open</a>
                        
                     </p>
                     <a href="http://publicaccess.nih.gov/submit_process_journals.htm">
                        <img alt="PMC Logo" src="http://www.oxfordjournals.org/resource/image/pmc-logo.gif" />
                        </a>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://publicaccess.nih.gov/submit_process_journals.htm" rel=""
                              title="This journal enables compliance with the NIH Public Access Policy">This journal enables compliance with the NIH Public Access Policy</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="alerting_services" title="Alerting Services"><span>Alerting Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email table of contents">Email table of contents</a>
                           
                        </li>
                        <li>
                           <a href="/cgi/alerts/etoc" rel="" title="Email Advance Access">Email Advance Access</a>
                           
                        </li>
                        <li>
                           <a href="http://jnci.oxfordjournals.org/help/citetrack/index.dtl" rel=""
                              title="CiteTrack">CiteTrack</a>
                           
                        </li>
                        <li>
                           <a href="/rss" rel="" title="XML RSS feed">XML RSS feed</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="corporate_services" title="Corporate Services"><span>Corporate Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/advertising.html" rel=""
                              title="Advertising sales">Advertising sales</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/reprints.html" rel=""
                              title="Reprints">Reprints</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/classifiedadinprint.html"
                              rel=""
                              title="Classified Advertising">Classified Advertising</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
               </div>
               <script type="text/javascript">var taxonomies = ["MED00300"];</script>
               </div>
            
            <div class="most-links-box js-marker">
               
               <div class="most-header">
                  
                  <h3>Most</h3>
                  
               </div>
               
               <ul>
                  <li class="most-cur-sel">
                     <h4>Most Read</h4>
                     	  
                     <div class="most-list">
                        	    
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/6/443?rss=1&amp;ssource=mfr">Breast Density and Cancer Risk: What Is the Relationship?</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/9/713?rss=1&amp;ssource=mfr">The Female Prostate</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/91/14/1194?rss=1&amp;ssource=mfr">Tobacco Smoke Carcinogens and Lung Cancer</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/107/6/djv048?rss=1&amp;ssource=mfr">Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity,
                                 Poverty, and State</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/105/23/1799?rss=1&amp;ssource=mfr">Elevated Plasma Vitamin B12 Levels as a Marker for Cancer: A Population-Based Cohort Study</a></li>
                        </ol>
                        	    <a href="http://jnci.oxfordjournals.org/reports/mfr1.dtl" class="view-all">» View all Most Read articles</a>
                        	  
                     </div>
                     	
                  </li>
                  <li>
                     <h4>Most Cited</h4>
                     	
                     <div class="most-list">
                        	  
                        <ol>
                           <li class="first-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/92/3/205?rss=1&amp;ssource=mfc">New Guidelines to Evaluate the Response to Treatment in Solid Tumors</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/90/18/1371?rss=1&amp;ssource=mfc">Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/85/5/365?rss=1&amp;ssource=mfc">The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International
                                 Clinical Trials in Oncology</a></li>
                           <li><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/13/1107?rss=1&amp;ssource=mfc">New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening</a></li>
                           <li class="last-item"><a href="http://jnci.oxfordjournals.org/cgi/content/short/82/1/4?rss=1&amp;ssource=mfc">What Is the Evidence That Tumors Are Angiogenesis Dependent?</a></li>
                        </ol>
                        	  <a href="http://jnci.oxfordjournals.org/reports/mfc1.dtl" class="view-all">» View all Most Cited articles</a>
                        	
                     </div>
                     
                  </li>
               </ul>
               
            </div>
            
            
            
         </div>
         
         
         
         <div id="oas_bottom" class="ad_hidden">
            <iframe id="id_advertframe_bottom"
                    src="/resource/htmlfiles/advert.html?p=Bottom&amp;u=jnci.oxfordjournals.org/content/97/3/188.full"
                    width="0"
                    height="0"
                    frameborder="0"
                    scrolling="no"
                    class="resize_ad"></iframe>
            
         </div>
         
         
         
         
         
         
         <div id="secondary_footer">
            
            <div id="issn">Online ISSN 1460-2105 - Print ISSN 0027-8874</div>
            
            
            <div id="copyright"><a href="http://www.oxfordjournals.org/our_journals/terms.html">Copyright ©</a> 
               <span>2015</span> Oxford University Press
               
            </div>
            
         </div>
         
         <div id="primary_footer">
            
            <div id="site_logo">
               <strong><span>Oxford Journals</span></strong>
               <em><span>Oxford University Press</span></em>
               
            </div>
            
            
            <div id="third_nav">
               
               <ul>
                  <li><a href="http://www.oxfordjournals.org/site_map.html">Site Map</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/privacy_policy.html">Privacy Policy</a></li>
                  <li><a href="http://global.oup.com/cookiepolicy/?siteid=journals">Cookie Policy</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/legal_notices.html">Legal Notices</a></li>
                  <li><a href="http://www.oxfordjournals.org/faq/">Frequently Asked Questions</a></li>
               </ul>
               
            </div>
            
            
            <div id="other_oup_sites">
               
               <form action="http://www.oxfordjournals.org/service/redirect">
                  <div>
                     <label for="site_list">Other Oxford University Press sites:</label>
                     <select name="url" id="site_list">
                        <option value="http://www.oup.com">Oxford University Press</option>
                        <option value="http://www.oxfordjournals.org/china/">Oxford Journals China</option>
                        <option value="http://www.oxfordjournals.org/japan/">Oxford Journals Japan</option>
                        <option value="http://www.oup.com/uk/academic">Academic &amp; Professional books</option>
                        <option value="http://www.oup.com/oxed">Children's &amp; Schools Books</option>
                        <option value="http://www.oup.com/uk/dictionaries">Dictionaries &amp; Reference</option>
                        <option value="http://www.oup.co.uk/newdnb/">Dictionary of National Biography</option>
                        <option value="http://www.oup.com/uk/digital_reference">Digital Reference</option>
                        <option value="http://www.oup.com/elt/">English Language Teaching</option>
                        <option value="http://www.oup.com/uk/textbooks">Higher Education Textbooks</option>
                        <option value="http://www.oup.co.uk/ieu/">International Education Unit</option>
                        <option value="http://www.oup.com/uk/law">Law</option>
                        <option value="http://www.oup.com/uk/medicine">Medicine</option>
                        <option value="http://www.oup.com/uk/music">Music</option>
                        <option value="http://www.oup.com/online">Online Products &amp; Publishing</option>
                        <option value="http://oxfordbibliographiesonline.com">Oxford Bibliographies Online</option>
                        <option value="http://oxforddictionaries.com">Oxford Dictionaries Online</option>
                        <option value="http://www.oed.com">Oxford English Dictionary</option>
                        <option value="http://www.oxfordlanguagedictionaries.com">Oxford Language Dictionaries Online</option>
                        <option value="http://www.oxfordscholarship.com">Oxford Scholarship Online</option>
                        <option value="http://www.oup.com/uk/reference">Reference</option>
                        <option value="http://www.oup.com/uk/rights">Rights and Permissions</option>
                        <option value="http://www.oup.com/uk/booksellers">Resources for Retailers &amp; Wholesalers</option>
                        <option value="http://www.oup.com/uk/corporate">Resources for the Healthcare Industry</option>
                        <option value="http://www.oup.com/vsi">Very Short Introductions</option>
                        <option value="http://www.oup.com/worldsclassics">World's Classics</option></select>
                     
                     <input type="image" src="/resource/image/buttons/go.gif" alt="Go"
                            class="inline_button" />
                     
                  </div>
               </form>
               
            </div>
            
         </div>
         <script type="text/javascript"
                 src="http://gab.cookie.oup.com/aws-cookie/oup.cookiepolicy.pack.js"
                 defer="defer"></script>
         
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jquery-ui.min.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/jcarousellite.js"
                 type="text/javascript"></script>
         <script defer="defer"
                 src="http://oi-underbar.ifactory.com/underbar/js/pf_oiunderbarinit.js"
                 type="text/javascript"></script>
         <script defer="defer" src="/resource/js/underbar_local.js" type="text/javascript"></script>
         <script defer="defer" type="text/javascript">
    function fnc_onDomLoaded() {
        var query_context = getQueryContext();
        PF_initOIUnderbar(query_context,":QS:default","","JRN"); 
        PF_insertOIUnderbar(0);
    };
    if (window.addEventListener) { 
        window.addEventListener('load', fnc_onDomLoaded, false); 
    } else if (window.attachEvent) { 
        window.attachEvent('onload', fnc_onDomLoaded); 
    } 
</script>
         <noscript><img src="//ouptag.scholarlyiq.com/ntpagetag.gif?js=0" height="1" width="1"
                 border="0"
                 hspace="0"
                 vspace="0"
                 alt="" /></noscript><script type="text/javascript" src="//ouptag.scholarlyiq.com/ntpagetag.js"></script><script type="text/javascript">
        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script type="text/javascript">
        try {
        var pageTracker = _gat._getTracker("UA-189672-16");
        pageTracker._setDomainName(".oxfordjournals.org");
        pageTracker._trackPageview();
        } catch(err) {}
        </script></div>
   </body>
</html>